anisomycin  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Cell Signaling Technology Inc anisomycin
    Dioscin inhibits macrophages and fibroblasts from secreting pro-inflammatory cytokines. (A) Western blot analyses of ASK1 phosphorylation and downstream MAPK proteins (p38 and JNK/SAPK) in LPS-primed RAW 264.7 macrophages treated with CS (50 μg/cm 2 ) together with different does of dioscin for 6 h. <t>Anisomycin</t> was used to reverse dioscin's effect (2 ng/mL). Quantification of each protein level relative to β-Actin is shown below each band . (B-D) The levels of phospho-ASK1, phospho-p38 and phosphor-JNK were normalized to those of β-Actin (n=3). (E-H) ELISA analyses of pro-inflammation cytokines in the culture medium of different treated macrophages at 6 h. (E) MCP-1, (F) IL-1β, (G) IL-6, (H)TNF-α (n=3). Data are the mean of three independent experiments (n=3). (I) Western blot analyses of ASK1 phosphorylation and downstream MAPK proteins (p38 and JNK/SAPK) in TNF-α- (25 ng/mL) treated NIH-3T3 fibroblasts together with different does of dioscin for 30 min. Quantification of each protein level relative to β-Actin is shown below each band . (J-L) The levels of phospho-ASK1, phospho-p38 and phosphor-JNK were normalized to those of β-Actin (n=3). (M) qPCR analysis of Il-6 mRNA levels in TNF-α- (25 ng/mL) treated fibroblasts together with different concentrations of dioscin for 12 h (n=3). *, P<0.05; **, P<0.01. Error bars indicate the mean ± SD. The experiment was performed twice with similar results.
    Anisomycin, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anisomycin/product/Cell Signaling Technology Inc
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anisomycin - by Bioz Stars, 2023-03
    93/100 stars

    Images

    1) Product Images from "Dioscin Exerts Protective Effects Against Crystalline Silica-induced Pulmonary Fibrosis in Mice"

    Article Title: Dioscin Exerts Protective Effects Against Crystalline Silica-induced Pulmonary Fibrosis in Mice

    Journal: Theranostics

    doi: 10.7150/thno.20270

    Dioscin inhibits macrophages and fibroblasts from secreting pro-inflammatory cytokines. (A) Western blot analyses of ASK1 phosphorylation and downstream MAPK proteins (p38 and JNK/SAPK) in LPS-primed RAW 264.7 macrophages treated with CS (50 μg/cm 2 ) together with different does of dioscin for 6 h. Anisomycin was used to reverse dioscin's effect (2 ng/mL). Quantification of each protein level relative to β-Actin is shown below each band . (B-D) The levels of phospho-ASK1, phospho-p38 and phosphor-JNK were normalized to those of β-Actin (n=3). (E-H) ELISA analyses of pro-inflammation cytokines in the culture medium of different treated macrophages at 6 h. (E) MCP-1, (F) IL-1β, (G) IL-6, (H)TNF-α (n=3). Data are the mean of three independent experiments (n=3). (I) Western blot analyses of ASK1 phosphorylation and downstream MAPK proteins (p38 and JNK/SAPK) in TNF-α- (25 ng/mL) treated NIH-3T3 fibroblasts together with different does of dioscin for 30 min. Quantification of each protein level relative to β-Actin is shown below each band . (J-L) The levels of phospho-ASK1, phospho-p38 and phosphor-JNK were normalized to those of β-Actin (n=3). (M) qPCR analysis of Il-6 mRNA levels in TNF-α- (25 ng/mL) treated fibroblasts together with different concentrations of dioscin for 12 h (n=3). *, P<0.05; **, P<0.01. Error bars indicate the mean ± SD. The experiment was performed twice with similar results.
    Figure Legend Snippet: Dioscin inhibits macrophages and fibroblasts from secreting pro-inflammatory cytokines. (A) Western blot analyses of ASK1 phosphorylation and downstream MAPK proteins (p38 and JNK/SAPK) in LPS-primed RAW 264.7 macrophages treated with CS (50 μg/cm 2 ) together with different does of dioscin for 6 h. Anisomycin was used to reverse dioscin's effect (2 ng/mL). Quantification of each protein level relative to β-Actin is shown below each band . (B-D) The levels of phospho-ASK1, phospho-p38 and phosphor-JNK were normalized to those of β-Actin (n=3). (E-H) ELISA analyses of pro-inflammation cytokines in the culture medium of different treated macrophages at 6 h. (E) MCP-1, (F) IL-1β, (G) IL-6, (H)TNF-α (n=3). Data are the mean of three independent experiments (n=3). (I) Western blot analyses of ASK1 phosphorylation and downstream MAPK proteins (p38 and JNK/SAPK) in TNF-α- (25 ng/mL) treated NIH-3T3 fibroblasts together with different does of dioscin for 30 min. Quantification of each protein level relative to β-Actin is shown below each band . (J-L) The levels of phospho-ASK1, phospho-p38 and phosphor-JNK were normalized to those of β-Actin (n=3). (M) qPCR analysis of Il-6 mRNA levels in TNF-α- (25 ng/mL) treated fibroblasts together with different concentrations of dioscin for 12 h (n=3). *, P<0.05; **, P<0.01. Error bars indicate the mean ± SD. The experiment was performed twice with similar results.

    Techniques Used: Western Blot, Enzyme-linked Immunosorbent Assay

    Dioscin regulated the TGF-β1-Samd3 signaling pathway and regulatory T cell functions. (A, B) Western blot analysis and quantification of TGF-β1 in lungs of dioscin-treated mice at 56 d (n=3). β-Actin was used as the loading control. Quantification of TGF-β1 levels relative to β-Actin is shown below the band. (C) qPCR analysis of Tgf-β1 in the lung tissues (n=6-8 per group). *, P<0.05; **, P<0.01. Error bars indicate the mean ± SD. The experiment was performed in triplicate. (D, E) Western blot analysis and quantification of Smad3 signaling in the lungs of treated mice at 56 d (n=3). β-Actin was used as the loading control. Quantification of p-Smad3 levels relative to β-Actin is shown below the band. (F, G) Western blot analysis of p-Smad3 and Smad3 in NIH-3T3 fibroblast, 30 min after TGF-β1 (5 ng/mL) and dioscin treatment. Quantification of p-Smad3 levels relative to β-Actin is shown below the band. (H) Schematic design of transwell experiment: RAW 264.7 macrophages were primed by LPS (25 ng/mL) for 3 h, and then treated with CS (50 μg/cm 2 ) together with dioscin or anisomycin (2 ng/mL) for 24 h in the lower plate, while NIH-3T3 fibroblasts were attached in the upper chamber. After that, the upper chamber was inserted back to the lower plate, and macrophages and fibroblasts were co-cultured for another 24 h. Then, the mRNA expressions of Col1a1 (I) and α-SMA (J) in NIH-3T3 fibroblast were determined by qPCR (n=3). (K, L) Percentage of CD4+CD25+FoxP3+ cells (regulatory T cells) in hilar lymph nodes was assayed by FACS analysis (n=5). *, P<0.05; **, P<0.01. Error bars indicate the mean ± SD.
    Figure Legend Snippet: Dioscin regulated the TGF-β1-Samd3 signaling pathway and regulatory T cell functions. (A, B) Western blot analysis and quantification of TGF-β1 in lungs of dioscin-treated mice at 56 d (n=3). β-Actin was used as the loading control. Quantification of TGF-β1 levels relative to β-Actin is shown below the band. (C) qPCR analysis of Tgf-β1 in the lung tissues (n=6-8 per group). *, P<0.05; **, P<0.01. Error bars indicate the mean ± SD. The experiment was performed in triplicate. (D, E) Western blot analysis and quantification of Smad3 signaling in the lungs of treated mice at 56 d (n=3). β-Actin was used as the loading control. Quantification of p-Smad3 levels relative to β-Actin is shown below the band. (F, G) Western blot analysis of p-Smad3 and Smad3 in NIH-3T3 fibroblast, 30 min after TGF-β1 (5 ng/mL) and dioscin treatment. Quantification of p-Smad3 levels relative to β-Actin is shown below the band. (H) Schematic design of transwell experiment: RAW 264.7 macrophages were primed by LPS (25 ng/mL) for 3 h, and then treated with CS (50 μg/cm 2 ) together with dioscin or anisomycin (2 ng/mL) for 24 h in the lower plate, while NIH-3T3 fibroblasts were attached in the upper chamber. After that, the upper chamber was inserted back to the lower plate, and macrophages and fibroblasts were co-cultured for another 24 h. Then, the mRNA expressions of Col1a1 (I) and α-SMA (J) in NIH-3T3 fibroblast were determined by qPCR (n=3). (K, L) Percentage of CD4+CD25+FoxP3+ cells (regulatory T cells) in hilar lymph nodes was assayed by FACS analysis (n=5). *, P<0.05; **, P<0.01. Error bars indicate the mean ± SD.

    Techniques Used: Western Blot, Cell Culture

    anisomycin  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Cell Signaling Technology Inc anisomycin
    Distinct set of genes and pathways upregulated in the <t>anisomycin-treated</t> 130429/160915 cells and p38–130429/160915 cells. ( A ): Principal component analysis of 30 min anisomycin-treated 130429/160915 cells compared with DMSO-treated 130429/160915 cells (normalized + log2). Volcano plot showing differentially expressed genes (DEGs) in 30 min anisomycin-treated 130429/160915 cells compared with DMSO-treated 130429/160915 cells (FDR threshold: 0.05). The most upregulated and downregulated pathway as indicated by the over-representation analysis (ORA), p -value < 0.05. ( B ): Principal component analysis of p38–130429/160915 cells compared with EV control–130429/160915 cells (normalized + log2). Volcano plot showing differentially expressed genes (DEGs) in p38–130429/160915 cells compared with EV control–130429/160915 cells (FDR threshold: 0.05). Most upregulated pathway as indicated by over-representation analysis (ORA) and most downregulated pathway as indicated by KEGG, p -value < 0.05.
    Anisomycin, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anisomycin/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anisomycin - by Bioz Stars, 2023-03
    86/100 stars

    Images

    1) Product Images from "P38 Mediates Tumor Suppression through Reduced Autophagy and Actin Cytoskeleton Changes in NRAS-Mutant Melanoma"

    Article Title: P38 Mediates Tumor Suppression through Reduced Autophagy and Actin Cytoskeleton Changes in NRAS-Mutant Melanoma

    Journal: Cancers

    doi: 10.3390/cancers15030877

    Distinct set of genes and pathways upregulated in the anisomycin-treated 130429/160915 cells and p38–130429/160915 cells. ( A ): Principal component analysis of 30 min anisomycin-treated 130429/160915 cells compared with DMSO-treated 130429/160915 cells (normalized + log2). Volcano plot showing differentially expressed genes (DEGs) in 30 min anisomycin-treated 130429/160915 cells compared with DMSO-treated 130429/160915 cells (FDR threshold: 0.05). The most upregulated and downregulated pathway as indicated by the over-representation analysis (ORA), p -value < 0.05. ( B ): Principal component analysis of p38–130429/160915 cells compared with EV control–130429/160915 cells (normalized + log2). Volcano plot showing differentially expressed genes (DEGs) in p38–130429/160915 cells compared with EV control–130429/160915 cells (FDR threshold: 0.05). Most upregulated pathway as indicated by over-representation analysis (ORA) and most downregulated pathway as indicated by KEGG, p -value < 0.05.
    Figure Legend Snippet: Distinct set of genes and pathways upregulated in the anisomycin-treated 130429/160915 cells and p38–130429/160915 cells. ( A ): Principal component analysis of 30 min anisomycin-treated 130429/160915 cells compared with DMSO-treated 130429/160915 cells (normalized + log2). Volcano plot showing differentially expressed genes (DEGs) in 30 min anisomycin-treated 130429/160915 cells compared with DMSO-treated 130429/160915 cells (FDR threshold: 0.05). The most upregulated and downregulated pathway as indicated by the over-representation analysis (ORA), p -value < 0.05. ( B ): Principal component analysis of p38–130429/160915 cells compared with EV control–130429/160915 cells (normalized + log2). Volcano plot showing differentially expressed genes (DEGs) in p38–130429/160915 cells compared with EV control–130429/160915 cells (FDR threshold: 0.05). Most upregulated pathway as indicated by over-representation analysis (ORA) and most downregulated pathway as indicated by KEGG, p -value < 0.05.

    Techniques Used:

    Invasion assay in spheroids and protein expression of MITF. ( A ): EV control–160915 and p38–160915 spheroids were stained with calcein and ethidium and compared at 24, 48 and 72 h post-embedding in collagen with and without anisomycin/DMSO. ( B ): Total area was compared at 24, 48 and 72 h post-embedding in collagen in addition to comparing the total area between DMSO, 0.01 µM, and 0.1 µM anisomycin treatments lasting 24 and 48 h in both EV control–160915 and p38–160915. A significant difference was observed between EV control–160915 and p38–160915 at 24 h post embedding in collagen and prior to anisomycin treatment ( p = 0.0138). as well as 72 h post-embedding in collagen and 48 h post 0.01 µM anisomycin treatment ( p = 0.0197). Bars labelled as pre-DMSO/aniso refer to the spheres before the respective treatments. ( C ): Fragmentation was compared at 24, 48, and 72 h post-embedding in collagen in addition to a comparison of the fragmentation between DMSO, 0.01 µM, and 0.1 µM anisomycin treatments lasting 24 and 48 h in both EV control–160915 and p38–160915. A significant difference was observed between EV control–160915 and p38–160915 24 and 48 h post-DMSO treatment ( p < 0.0001). Bars labelled as pre-DMSO/aniso refer to the spheres before the respective treatments. ( D ): Invasion distance was compared at 24, 48, and 72 h post-embedding in collagen in addition to a comparison of the invasion distance between DMSO, 0.01 µM, and 0.1 µM anisomycin treatments lasting 24 and 48 h in both EV control–160915 and p38–160915. A significant difference was observed between EV control–160915 and p38–160915 24 and 48 h post-0.01 µM anisomycin treatment ( p < 0.0001). Invasion distance was calculated using images from the confocal microscope. ( E ): Total area was calculated using the same methods as in B except that the comparison group is limited to EV control–160915 only. ( F ): Fragmentation was calculated using the same methods as in C except that the comparison group is limited to EV control–160915 only. A significant difference was observed between 24 h DMSO-treated spheroids and 0.01 µM anisomycin treated spheres at 24 and 48 h ( p < 0.0001). ( G ): Invasion distance was calculated using the same methods as in D except that the comparison group is limited to EV control–160915 only. A significant difference was observed between 48 h post-embedding in collagen and 0.1 µM anisomycin treatment at 24 ( p < 0.002) and 48 h ( p < 0.0001). A significant difference was observed between DMSO-treated spheroids and 0.1 µM anisomycin-treated spheroids at 24 ( p < 0.0027) and 48 h ( p < 0.001). This is a representative picture of one replicate out of the three biological replicates. The Experiment was repeated at least three times with three biological replicates.
    Figure Legend Snippet: Invasion assay in spheroids and protein expression of MITF. ( A ): EV control–160915 and p38–160915 spheroids were stained with calcein and ethidium and compared at 24, 48 and 72 h post-embedding in collagen with and without anisomycin/DMSO. ( B ): Total area was compared at 24, 48 and 72 h post-embedding in collagen in addition to comparing the total area between DMSO, 0.01 µM, and 0.1 µM anisomycin treatments lasting 24 and 48 h in both EV control–160915 and p38–160915. A significant difference was observed between EV control–160915 and p38–160915 at 24 h post embedding in collagen and prior to anisomycin treatment ( p = 0.0138). as well as 72 h post-embedding in collagen and 48 h post 0.01 µM anisomycin treatment ( p = 0.0197). Bars labelled as pre-DMSO/aniso refer to the spheres before the respective treatments. ( C ): Fragmentation was compared at 24, 48, and 72 h post-embedding in collagen in addition to a comparison of the fragmentation between DMSO, 0.01 µM, and 0.1 µM anisomycin treatments lasting 24 and 48 h in both EV control–160915 and p38–160915. A significant difference was observed between EV control–160915 and p38–160915 24 and 48 h post-DMSO treatment ( p < 0.0001). Bars labelled as pre-DMSO/aniso refer to the spheres before the respective treatments. ( D ): Invasion distance was compared at 24, 48, and 72 h post-embedding in collagen in addition to a comparison of the invasion distance between DMSO, 0.01 µM, and 0.1 µM anisomycin treatments lasting 24 and 48 h in both EV control–160915 and p38–160915. A significant difference was observed between EV control–160915 and p38–160915 24 and 48 h post-0.01 µM anisomycin treatment ( p < 0.0001). Invasion distance was calculated using images from the confocal microscope. ( E ): Total area was calculated using the same methods as in B except that the comparison group is limited to EV control–160915 only. ( F ): Fragmentation was calculated using the same methods as in C except that the comparison group is limited to EV control–160915 only. A significant difference was observed between 24 h DMSO-treated spheroids and 0.01 µM anisomycin treated spheres at 24 and 48 h ( p < 0.0001). ( G ): Invasion distance was calculated using the same methods as in D except that the comparison group is limited to EV control–160915 only. A significant difference was observed between 48 h post-embedding in collagen and 0.1 µM anisomycin treatment at 24 ( p < 0.002) and 48 h ( p < 0.0001). A significant difference was observed between DMSO-treated spheroids and 0.1 µM anisomycin-treated spheroids at 24 ( p < 0.0027) and 48 h ( p < 0.001). This is a representative picture of one replicate out of the three biological replicates. The Experiment was repeated at least three times with three biological replicates.

    Techniques Used: Invasion Assay, Expressing, Staining, Microscopy

    First and second panel: Protein expression of MITF with HSP90 as loading control under the untreated, DMSO, 0.1 µM anisomycin for 30 min, and 0.1 µM anisomycin for 24 h treatment conditions in cell lines 134029 and 160915. Third and fourth panel: Protein expression of MITF with HSP90 as loading control under the untreated, DMSO, and 0.1 µM anisomycin for 30 min treatment conditions in cell lines EV control–130429/160915 and p38–130429/160915.
    Figure Legend Snippet: First and second panel: Protein expression of MITF with HSP90 as loading control under the untreated, DMSO, 0.1 µM anisomycin for 30 min, and 0.1 µM anisomycin for 24 h treatment conditions in cell lines 134029 and 160915. Third and fourth panel: Protein expression of MITF with HSP90 as loading control under the untreated, DMSO, and 0.1 µM anisomycin for 30 min treatment conditions in cell lines EV control–130429/160915 and p38–130429/160915.

    Techniques Used: Expressing

    Beta-catenin expression and cell motility assay. Immunofluorescence staining of beta-catenin (green) and nucleus (blue) in cell lines 130429, 160915, EV control–130429/160915, and p38–130429/160915 under DMSO, 0.1 µM anisomycin for 30 min, and 0.1 µM anisomycin for 24 h.
    Figure Legend Snippet: Beta-catenin expression and cell motility assay. Immunofluorescence staining of beta-catenin (green) and nucleus (blue) in cell lines 130429, 160915, EV control–130429/160915, and p38–130429/160915 under DMSO, 0.1 µM anisomycin for 30 min, and 0.1 µM anisomycin for 24 h.

    Techniques Used: Expressing, Motility Assay, Immunofluorescence, Staining

    ( A ): Immunofluorescence staining of nucleus (blue) in cell lines 130429, 160915, 130227, EV control–130429/160915, and p38–130429/160915 under DMSO and 0.1 µM anisomycin for 24 h. ( B ): Cell counts from immunofluorescence staining of nucleus in cell type 130429, EV control–130429, and p38–130429 under varying treatment conditions. Significant difference observed in anisomycin-treated cells compared with DMSO-treated ( p = 0.0034) and untreated cells ( p = 0.004). ( C ): Cell counts from immunofluorescence staining of nucleus in 160915, EV control–160915, and p38–160915 under varying treatment conditions. ( D ): Cell counts from immunofluorescence staining of the nucleus in cell line 130227 under varying treatment conditions.
    Figure Legend Snippet: ( A ): Immunofluorescence staining of nucleus (blue) in cell lines 130429, 160915, 130227, EV control–130429/160915, and p38–130429/160915 under DMSO and 0.1 µM anisomycin for 24 h. ( B ): Cell counts from immunofluorescence staining of nucleus in cell type 130429, EV control–130429, and p38–130429 under varying treatment conditions. Significant difference observed in anisomycin-treated cells compared with DMSO-treated ( p = 0.0034) and untreated cells ( p = 0.004). ( C ): Cell counts from immunofluorescence staining of nucleus in 160915, EV control–160915, and p38–160915 under varying treatment conditions. ( D ): Cell counts from immunofluorescence staining of the nucleus in cell line 130227 under varying treatment conditions.

    Techniques Used: Immunofluorescence, Staining

    Transient phosphorylation of mTOR/AKT and cJUN pathway with short-term anisomycin treatment and sustained phosphorylation of mTOR in long-term anisomycin-treated and p38–130429/160915 cells. ( A ): Protein expression of phospho-mTOR, AKT, p90, and cJUN with HSP90 as the loading control under untreated, DMSO, and 0.1 µM anisomycin treatment for 30 min and 24 h in cell line 130429. Densitometry plot represents the expression of proteins as the fold change in relation to HSP90 expression. ( B ): Protein expression of phospho-mTOR, AKT, p90, and cJUN with HSP90 as the loading control under untreated, DMSO, and 0.1 µM anisomycin treatment for 30 min and 24 h in cell line 160915. Densitometry plot represents the expression of proteins as the fold change in relation to HSP90 expression. ( C ): Protein expression of hosphor-mTOR, AKT, p90, and cJUN with HSP90 as the loading control under untreated, DMSO, and 0.1 µM anisomycin treatment for 30 min in EV control–130429 and p38–130429 cell lines. Densitometry plot represents the expression of proteins as the fold change in relation to HSP90 expression. ( D ): Protein expression of phospho-mTOR, AKT, p90, and cJUN with HSP90 as the loading control under untreated, DMSO, and 0.1 µM anisomycin treatment for 30 min in EV control–160915 and p38–160915 cell lines. Densitometry plot represents the expression of proteins as the fold change in relation to HSP90 expression.
    Figure Legend Snippet: Transient phosphorylation of mTOR/AKT and cJUN pathway with short-term anisomycin treatment and sustained phosphorylation of mTOR in long-term anisomycin-treated and p38–130429/160915 cells. ( A ): Protein expression of phospho-mTOR, AKT, p90, and cJUN with HSP90 as the loading control under untreated, DMSO, and 0.1 µM anisomycin treatment for 30 min and 24 h in cell line 130429. Densitometry plot represents the expression of proteins as the fold change in relation to HSP90 expression. ( B ): Protein expression of phospho-mTOR, AKT, p90, and cJUN with HSP90 as the loading control under untreated, DMSO, and 0.1 µM anisomycin treatment for 30 min and 24 h in cell line 160915. Densitometry plot represents the expression of proteins as the fold change in relation to HSP90 expression. ( C ): Protein expression of hosphor-mTOR, AKT, p90, and cJUN with HSP90 as the loading control under untreated, DMSO, and 0.1 µM anisomycin treatment for 30 min in EV control–130429 and p38–130429 cell lines. Densitometry plot represents the expression of proteins as the fold change in relation to HSP90 expression. ( D ): Protein expression of phospho-mTOR, AKT, p90, and cJUN with HSP90 as the loading control under untreated, DMSO, and 0.1 µM anisomycin treatment for 30 min in EV control–160915 and p38–160915 cell lines. Densitometry plot represents the expression of proteins as the fold change in relation to HSP90 expression.

    Techniques Used: Expressing

    Transient suppression of autophagy by reduced conversion of LC3 with p38 activation. ( A ): Protein expression of LC3 with HSP90 as the loading control under untreated, DMSO, 0.1 µM anisomycin treatment for 30 min or 24 h, and 10 µM HCQ treatment for 24 h in cell line 130429. Densitometry plot represents the expression of proteins as the fold change in relation to HSP90 expression. ( B ): Protein expression of LC3 with HSP90 as the loading control under untreated, DMSO, 0.1 µM anisomycin treatment for 30 min or 24 h, and 10 µM HCQ treatment for 24 h in cell line 160915. Densitometry plot represents the expression of proteins as the fold change in relation to HSP90 expression. ( C ): Protein expression of p62 and LC3 with HSP90 as the loading control under untreated, DMSO, 0.1 µM anisomycin treatment or 24 h, and 10 µM HCQ treatment for 24 h in EV control–130429 and p38–130429 cell lines. Densitometry plot represents the expression of proteins as the fold change in relation to HSP90 expression. ( D ): Protein expression of LC3 with HSP90 as the loading control under untreated, DMSO, 0.1 µM anisomycin treatment for 30 min or 24 h, and 10 µM HCQ treatment for 24 h in EV control–160915 and p38–160915 cell lines. Densitometry plot represents the expression of proteins as the fold change in relation to HSP90 expression.
    Figure Legend Snippet: Transient suppression of autophagy by reduced conversion of LC3 with p38 activation. ( A ): Protein expression of LC3 with HSP90 as the loading control under untreated, DMSO, 0.1 µM anisomycin treatment for 30 min or 24 h, and 10 µM HCQ treatment for 24 h in cell line 130429. Densitometry plot represents the expression of proteins as the fold change in relation to HSP90 expression. ( B ): Protein expression of LC3 with HSP90 as the loading control under untreated, DMSO, 0.1 µM anisomycin treatment for 30 min or 24 h, and 10 µM HCQ treatment for 24 h in cell line 160915. Densitometry plot represents the expression of proteins as the fold change in relation to HSP90 expression. ( C ): Protein expression of p62 and LC3 with HSP90 as the loading control under untreated, DMSO, 0.1 µM anisomycin treatment or 24 h, and 10 µM HCQ treatment for 24 h in EV control–130429 and p38–130429 cell lines. Densitometry plot represents the expression of proteins as the fold change in relation to HSP90 expression. ( D ): Protein expression of LC3 with HSP90 as the loading control under untreated, DMSO, 0.1 µM anisomycin treatment for 30 min or 24 h, and 10 µM HCQ treatment for 24 h in EV control–160915 and p38–160915 cell lines. Densitometry plot represents the expression of proteins as the fold change in relation to HSP90 expression.

    Techniques Used: Activation Assay, Expressing

    anisomycin  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Cell Signaling Technology Inc anisomycin
    Swim stress did not induce phosphorylation of MKK3/6. Note the absence of a band for P-MKK3/6 at ~40 kD, either in control or swim stressed hippocampal lysates, whereas an induced band is visible in the positive control cell extracts. Also note the unknown ~37 and 48 kD proteins induced by swim stress. Other brain regions examined exhibited a similar pattern. 3T3, lysates of NIH/3T3 cells treated with (+) or without (-) UV radiation (40 mJ, 45 minutes recovery time); C6, lysates of C6 glioma cells treated with (+) or without (-) <t>anisomycin</t> (25 μg/ml, 30 min); MW, molecular weight markers.
    Anisomycin, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anisomycin/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anisomycin - by Bioz Stars, 2023-03
    86/100 stars

    Images

    1) Product Images from "Activation of Erk and JNK MAPK pathways by acute swim stress in rat brain regions"

    Article Title: Activation of Erk and JNK MAPK pathways by acute swim stress in rat brain regions

    Journal: BMC Neuroscience

    doi: 10.1186/1471-2202-5-36

    Swim stress did not induce phosphorylation of MKK3/6. Note the absence of a band for P-MKK3/6 at ~40 kD, either in control or swim stressed hippocampal lysates, whereas an induced band is visible in the positive control cell extracts. Also note the unknown ~37 and 48 kD proteins induced by swim stress. Other brain regions examined exhibited a similar pattern. 3T3, lysates of NIH/3T3 cells treated with (+) or without (-) UV radiation (40 mJ, 45 minutes recovery time); C6, lysates of C6 glioma cells treated with (+) or without (-) anisomycin (25 μg/ml, 30 min); MW, molecular weight markers.
    Figure Legend Snippet: Swim stress did not induce phosphorylation of MKK3/6. Note the absence of a band for P-MKK3/6 at ~40 kD, either in control or swim stressed hippocampal lysates, whereas an induced band is visible in the positive control cell extracts. Also note the unknown ~37 and 48 kD proteins induced by swim stress. Other brain regions examined exhibited a similar pattern. 3T3, lysates of NIH/3T3 cells treated with (+) or without (-) UV radiation (40 mJ, 45 minutes recovery time); C6, lysates of C6 glioma cells treated with (+) or without (-) anisomycin (25 μg/ml, 30 min); MW, molecular weight markers.

    Techniques Used: Positive Control, Molecular Weight

    anisomycin  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Cell Signaling Technology Inc anisomycin
    Dioscin inhibits macrophages and fibroblasts from secreting pro-inflammatory cytokines. (A) Western blot analyses of ASK1 phosphorylation and downstream MAPK proteins (p38 and JNK/SAPK) in LPS-primed RAW 264.7 macrophages treated with CS (50 μg/cm 2 ) together with different does of dioscin for 6 h. <t>Anisomycin</t> was used to reverse dioscin's effect (2 ng/mL). Quantification of each protein level relative to β-Actin is shown below each band . (B-D) The levels of phospho-ASK1, phospho-p38 and phosphor-JNK were normalized to those of β-Actin (n=3). (E-H) ELISA analyses of pro-inflammation cytokines in the culture medium of different treated macrophages at 6 h. (E) MCP-1, (F) IL-1β, (G) IL-6, (H)TNF-α (n=3). Data are the mean of three independent experiments (n=3). (I) Western blot analyses of ASK1 phosphorylation and downstream MAPK proteins (p38 and JNK/SAPK) in TNF-α- (25 ng/mL) treated NIH-3T3 fibroblasts together with different does of dioscin for 30 min. Quantification of each protein level relative to β-Actin is shown below each band . (J-L) The levels of phospho-ASK1, phospho-p38 and phosphor-JNK were normalized to those of β-Actin (n=3). (M) qPCR analysis of Il-6 mRNA levels in TNF-α- (25 ng/mL) treated fibroblasts together with different concentrations of dioscin for 12 h (n=3). *, P<0.05; **, P<0.01. Error bars indicate the mean ± SD. The experiment was performed twice with similar results.
    Anisomycin, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anisomycin/product/Cell Signaling Technology Inc
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anisomycin - by Bioz Stars, 2023-03
    93/100 stars

    Images

    1) Product Images from "Dioscin Exerts Protective Effects Against Crystalline Silica-induced Pulmonary Fibrosis in Mice"

    Article Title: Dioscin Exerts Protective Effects Against Crystalline Silica-induced Pulmonary Fibrosis in Mice

    Journal: Theranostics

    doi: 10.7150/thno.20270

    Dioscin inhibits macrophages and fibroblasts from secreting pro-inflammatory cytokines. (A) Western blot analyses of ASK1 phosphorylation and downstream MAPK proteins (p38 and JNK/SAPK) in LPS-primed RAW 264.7 macrophages treated with CS (50 μg/cm 2 ) together with different does of dioscin for 6 h. Anisomycin was used to reverse dioscin's effect (2 ng/mL). Quantification of each protein level relative to β-Actin is shown below each band . (B-D) The levels of phospho-ASK1, phospho-p38 and phosphor-JNK were normalized to those of β-Actin (n=3). (E-H) ELISA analyses of pro-inflammation cytokines in the culture medium of different treated macrophages at 6 h. (E) MCP-1, (F) IL-1β, (G) IL-6, (H)TNF-α (n=3). Data are the mean of three independent experiments (n=3). (I) Western blot analyses of ASK1 phosphorylation and downstream MAPK proteins (p38 and JNK/SAPK) in TNF-α- (25 ng/mL) treated NIH-3T3 fibroblasts together with different does of dioscin for 30 min. Quantification of each protein level relative to β-Actin is shown below each band . (J-L) The levels of phospho-ASK1, phospho-p38 and phosphor-JNK were normalized to those of β-Actin (n=3). (M) qPCR analysis of Il-6 mRNA levels in TNF-α- (25 ng/mL) treated fibroblasts together with different concentrations of dioscin for 12 h (n=3). *, P<0.05; **, P<0.01. Error bars indicate the mean ± SD. The experiment was performed twice with similar results.
    Figure Legend Snippet: Dioscin inhibits macrophages and fibroblasts from secreting pro-inflammatory cytokines. (A) Western blot analyses of ASK1 phosphorylation and downstream MAPK proteins (p38 and JNK/SAPK) in LPS-primed RAW 264.7 macrophages treated with CS (50 μg/cm 2 ) together with different does of dioscin for 6 h. Anisomycin was used to reverse dioscin's effect (2 ng/mL). Quantification of each protein level relative to β-Actin is shown below each band . (B-D) The levels of phospho-ASK1, phospho-p38 and phosphor-JNK were normalized to those of β-Actin (n=3). (E-H) ELISA analyses of pro-inflammation cytokines in the culture medium of different treated macrophages at 6 h. (E) MCP-1, (F) IL-1β, (G) IL-6, (H)TNF-α (n=3). Data are the mean of three independent experiments (n=3). (I) Western blot analyses of ASK1 phosphorylation and downstream MAPK proteins (p38 and JNK/SAPK) in TNF-α- (25 ng/mL) treated NIH-3T3 fibroblasts together with different does of dioscin for 30 min. Quantification of each protein level relative to β-Actin is shown below each band . (J-L) The levels of phospho-ASK1, phospho-p38 and phosphor-JNK were normalized to those of β-Actin (n=3). (M) qPCR analysis of Il-6 mRNA levels in TNF-α- (25 ng/mL) treated fibroblasts together with different concentrations of dioscin for 12 h (n=3). *, P<0.05; **, P<0.01. Error bars indicate the mean ± SD. The experiment was performed twice with similar results.

    Techniques Used: Western Blot, Enzyme-linked Immunosorbent Assay

    Dioscin regulated the TGF-β1-Samd3 signaling pathway and regulatory T cell functions. (A, B) Western blot analysis and quantification of TGF-β1 in lungs of dioscin-treated mice at 56 d (n=3). β-Actin was used as the loading control. Quantification of TGF-β1 levels relative to β-Actin is shown below the band. (C) qPCR analysis of Tgf-β1 in the lung tissues (n=6-8 per group). *, P<0.05; **, P<0.01. Error bars indicate the mean ± SD. The experiment was performed in triplicate. (D, E) Western blot analysis and quantification of Smad3 signaling in the lungs of treated mice at 56 d (n=3). β-Actin was used as the loading control. Quantification of p-Smad3 levels relative to β-Actin is shown below the band. (F, G) Western blot analysis of p-Smad3 and Smad3 in NIH-3T3 fibroblast, 30 min after TGF-β1 (5 ng/mL) and dioscin treatment. Quantification of p-Smad3 levels relative to β-Actin is shown below the band. (H) Schematic design of transwell experiment: RAW 264.7 macrophages were primed by LPS (25 ng/mL) for 3 h, and then treated with CS (50 μg/cm 2 ) together with dioscin or anisomycin (2 ng/mL) for 24 h in the lower plate, while NIH-3T3 fibroblasts were attached in the upper chamber. After that, the upper chamber was inserted back to the lower plate, and macrophages and fibroblasts were co-cultured for another 24 h. Then, the mRNA expressions of Col1a1 (I) and α-SMA (J) in NIH-3T3 fibroblast were determined by qPCR (n=3). (K, L) Percentage of CD4+CD25+FoxP3+ cells (regulatory T cells) in hilar lymph nodes was assayed by FACS analysis (n=5). *, P<0.05; **, P<0.01. Error bars indicate the mean ± SD.
    Figure Legend Snippet: Dioscin regulated the TGF-β1-Samd3 signaling pathway and regulatory T cell functions. (A, B) Western blot analysis and quantification of TGF-β1 in lungs of dioscin-treated mice at 56 d (n=3). β-Actin was used as the loading control. Quantification of TGF-β1 levels relative to β-Actin is shown below the band. (C) qPCR analysis of Tgf-β1 in the lung tissues (n=6-8 per group). *, P<0.05; **, P<0.01. Error bars indicate the mean ± SD. The experiment was performed in triplicate. (D, E) Western blot analysis and quantification of Smad3 signaling in the lungs of treated mice at 56 d (n=3). β-Actin was used as the loading control. Quantification of p-Smad3 levels relative to β-Actin is shown below the band. (F, G) Western blot analysis of p-Smad3 and Smad3 in NIH-3T3 fibroblast, 30 min after TGF-β1 (5 ng/mL) and dioscin treatment. Quantification of p-Smad3 levels relative to β-Actin is shown below the band. (H) Schematic design of transwell experiment: RAW 264.7 macrophages were primed by LPS (25 ng/mL) for 3 h, and then treated with CS (50 μg/cm 2 ) together with dioscin or anisomycin (2 ng/mL) for 24 h in the lower plate, while NIH-3T3 fibroblasts were attached in the upper chamber. After that, the upper chamber was inserted back to the lower plate, and macrophages and fibroblasts were co-cultured for another 24 h. Then, the mRNA expressions of Col1a1 (I) and α-SMA (J) in NIH-3T3 fibroblast were determined by qPCR (n=3). (K, L) Percentage of CD4+CD25+FoxP3+ cells (regulatory T cells) in hilar lymph nodes was assayed by FACS analysis (n=5). *, P<0.05; **, P<0.01. Error bars indicate the mean ± SD.

    Techniques Used: Western Blot, Cell Culture

    anisomycin treated c6 cell extracts  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Cell Signaling Technology Inc anisomycin treated c6 cell extracts
    Anisomycin Treated C6 Cell Extracts, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anisomycin treated c6 cell extracts/product/Cell Signaling Technology Inc
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anisomycin treated c6 cell extracts - by Bioz Stars, 2023-03
    93/100 stars

    Images

    anisomycin  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Cell Signaling Technology Inc anisomycin
    Anisomycin, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anisomycin/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anisomycin - by Bioz Stars, 2023-03
    86/100 stars

    Images

    p38 mapk activator anisomycin  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Cell Signaling Technology Inc p38 mapk activator anisomycin
    Sequence alignment and domain analysis of S. mansoni <t>p38</t> <t>MAPK</t> . The S. mansoni putative <t>p38</t> <t>MAPK</t> sequence (XP_002571000) was aligned with those for S. japonicum MAPK14a, Homo sapiens (p38 MAPKα, also known as MAPK14 isoform 1), Drosophila melanogaster (p38a MAPK and p38b MAPK), Caenorhabditis elegans (p38 MAPK family member, PMK1) and Danio rerio (MAPK 14a); accession numbers are shown. Multiple alignments were achieved using Geneious Pro 4.85 with Blosum62 cost matrix and default settings; shading of residues: black = 100% similar, dark grey = 80-100% similar, light grey = 60-80% similar and white < 60% similar. The ATP binding site, kinase interacting motif (KIM) docking site, and activation loop are indicated by coloured arrows. Within the activation loop, the conserved Thr-Gly-Tyr (TGY) phosphorylation motif is highlighted by the yellow box, with the phosphorylated residues (Thr and Tyr) central to kinase activation indicated with green asterisks; the substrate binding site is shown by the orange box. Sequence highlighted by the blue box is that used to generate the monoclonal anti-phospho p38 MAPK antibodies. The residues within the ATP binding site that are known to confer specificity and sensitivity of SB 230580 towards p38 MAPK are highlighted by the red box with the residue (Thr) most responsible for p38 MAPK inhibition indicated by the red asterisk; red crosses denote other known interaction sites between SB 203580 and p38 MAPK (see text for further details).
    P38 Mapk Activator Anisomycin, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/p38 mapk activator anisomycin/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    p38 mapk activator anisomycin - by Bioz Stars, 2023-03
    86/100 stars

    Images

    1) Product Images from "A role for p38 MAPK in the regulation of ciliary motion in a eukaryote"

    Article Title: A role for p38 MAPK in the regulation of ciliary motion in a eukaryote

    Journal: BMC Cell Biology

    doi: 10.1186/1471-2121-12-6

    Sequence alignment and domain analysis of S. mansoni p38 MAPK . The S. mansoni putative p38 MAPK sequence (XP_002571000) was aligned with those for S. japonicum MAPK14a, Homo sapiens (p38 MAPKα, also known as MAPK14 isoform 1), Drosophila melanogaster (p38a MAPK and p38b MAPK), Caenorhabditis elegans (p38 MAPK family member, PMK1) and Danio rerio (MAPK 14a); accession numbers are shown. Multiple alignments were achieved using Geneious Pro 4.85 with Blosum62 cost matrix and default settings; shading of residues: black = 100% similar, dark grey = 80-100% similar, light grey = 60-80% similar and white < 60% similar. The ATP binding site, kinase interacting motif (KIM) docking site, and activation loop are indicated by coloured arrows. Within the activation loop, the conserved Thr-Gly-Tyr (TGY) phosphorylation motif is highlighted by the yellow box, with the phosphorylated residues (Thr and Tyr) central to kinase activation indicated with green asterisks; the substrate binding site is shown by the orange box. Sequence highlighted by the blue box is that used to generate the monoclonal anti-phospho p38 MAPK antibodies. The residues within the ATP binding site that are known to confer specificity and sensitivity of SB 230580 towards p38 MAPK are highlighted by the red box with the residue (Thr) most responsible for p38 MAPK inhibition indicated by the red asterisk; red crosses denote other known interaction sites between SB 203580 and p38 MAPK (see text for further details).
    Figure Legend Snippet: Sequence alignment and domain analysis of S. mansoni p38 MAPK . The S. mansoni putative p38 MAPK sequence (XP_002571000) was aligned with those for S. japonicum MAPK14a, Homo sapiens (p38 MAPKα, also known as MAPK14 isoform 1), Drosophila melanogaster (p38a MAPK and p38b MAPK), Caenorhabditis elegans (p38 MAPK family member, PMK1) and Danio rerio (MAPK 14a); accession numbers are shown. Multiple alignments were achieved using Geneious Pro 4.85 with Blosum62 cost matrix and default settings; shading of residues: black = 100% similar, dark grey = 80-100% similar, light grey = 60-80% similar and white < 60% similar. The ATP binding site, kinase interacting motif (KIM) docking site, and activation loop are indicated by coloured arrows. Within the activation loop, the conserved Thr-Gly-Tyr (TGY) phosphorylation motif is highlighted by the yellow box, with the phosphorylated residues (Thr and Tyr) central to kinase activation indicated with green asterisks; the substrate binding site is shown by the orange box. Sequence highlighted by the blue box is that used to generate the monoclonal anti-phospho p38 MAPK antibodies. The residues within the ATP binding site that are known to confer specificity and sensitivity of SB 230580 towards p38 MAPK are highlighted by the red box with the residue (Thr) most responsible for p38 MAPK inhibition indicated by the red asterisk; red crosses denote other known interaction sites between SB 203580 and p38 MAPK (see text for further details).

    Techniques Used: Sequencing, Binding Assay, Activation Assay, Inhibition

    Biochemical characterization of S. mansoni p38 MAPK . (A) Immunodetection of phosphorylated S. mansoni p38 MAPK. Protein from astrocytoma (U251 MG) cells (lane 1), 900 freshly-hatched swimming miracidia (lane 2), or an adult worm pair (lane 3) was processed for western blotting using anti-phospho p38 MAPK antibodies. (B) Activated S. mansoni p38 MAPK phosphorylates activating transcription factor-2 (ATF-2), and SB 203580 inhibits p38 MAPK activity. p38 MAPK from adult worm pairs was immunoprecipitated using immobilized anti-phospho p38 MAPK antibodies and the immunoprecipitated protein used in an in vitro kinase assay to phosphorylate ATF-2 either in the presence of SB 203580 (1-5 μM) or DMSO (D+), or with neither (D-). Phosphorylation of ATF-2 by immunoprecipitated p38 MAPK was assessed by western blotting using anti-phospho ATF-2 antibodies. (C) Anisomycin activates p38 MAPK in S. mansoni miracidia. Freshly-hatched miracidia were exposed to anisomycin (20 μM) for various durations and phosphorylation of p38 MAPK in miracidia detected by western blotting with anti-phospho p38 MAPK antibodies; blots were also probed with anti-actin antibodies to demonstrate equal protein loading between lanes. Results shown in (A-C) represent those obtained in at least two independent experiments.
    Figure Legend Snippet: Biochemical characterization of S. mansoni p38 MAPK . (A) Immunodetection of phosphorylated S. mansoni p38 MAPK. Protein from astrocytoma (U251 MG) cells (lane 1), 900 freshly-hatched swimming miracidia (lane 2), or an adult worm pair (lane 3) was processed for western blotting using anti-phospho p38 MAPK antibodies. (B) Activated S. mansoni p38 MAPK phosphorylates activating transcription factor-2 (ATF-2), and SB 203580 inhibits p38 MAPK activity. p38 MAPK from adult worm pairs was immunoprecipitated using immobilized anti-phospho p38 MAPK antibodies and the immunoprecipitated protein used in an in vitro kinase assay to phosphorylate ATF-2 either in the presence of SB 203580 (1-5 μM) or DMSO (D+), or with neither (D-). Phosphorylation of ATF-2 by immunoprecipitated p38 MAPK was assessed by western blotting using anti-phospho ATF-2 antibodies. (C) Anisomycin activates p38 MAPK in S. mansoni miracidia. Freshly-hatched miracidia were exposed to anisomycin (20 μM) for various durations and phosphorylation of p38 MAPK in miracidia detected by western blotting with anti-phospho p38 MAPK antibodies; blots were also probed with anti-actin antibodies to demonstrate equal protein loading between lanes. Results shown in (A-C) represent those obtained in at least two independent experiments.

    Techniques Used: Immunodetection, Western Blot, Activity Assay, Immunoprecipitation, In Vitro, Kinase Assay

    Activated p38 MAPK localizes to cilia in S. mansoni miracidia . (A) Scanning electron micrograph of the anterior of a freshly-hatched miracidium showing numerous cilia (c), and sensory endings (se) associated with the semi-spherical terebratorium (tb). (B - J) Immunolocalization of activated p38 MAPK (green) in S. mansoni miracidia following fixing and staining of parasites with anti-phospho p38 MAPK primary antibodies. (B) Freshly-hatched miracidium incubated without primary antibodies but with secondary antibodies alone (negative control). (C) Freshly-hatched swimming miracidium displaying weak patchy staining only localized adjacent to the tegument (tg) in areas corresponding to the cilia. (D) Serial optical z-section of a miracidium treated with 20 μM anisomycin for 30 min showing p38 MAPK activity in the regions occupied by cilia. (E and F) High power, optically zoomed, z-sections through discrete regions of cilia/tegument to capture the miracidium surface in one plane with (E) showing p38 MAPK localized to the shafts of the cilia (arrowed) and regions proximal to the tegument, and (F) showing co-localization with cilia (red) detected using anti-acetylated tubulin antibodies. (G) Miracidium treated with 20 μM anisomycin for 30 min for direct comparison with (C). (H) Autofluorescence (red) of S. mansoni egg containing (I, and J overlay) miracidium (m) with p38 MAPK activity in regions occupied by cilia. (K) Scanning electron micrograph of S. mansoni egg revealing common position of rupture during hatching, and correlating to rupture in H-J. Z-axis projections are shown in maximum pixel brightness mode. Bars: A, E and F = 2 μm; B-D, and G = 15 μm; H-K = 25 μm.
    Figure Legend Snippet: Activated p38 MAPK localizes to cilia in S. mansoni miracidia . (A) Scanning electron micrograph of the anterior of a freshly-hatched miracidium showing numerous cilia (c), and sensory endings (se) associated with the semi-spherical terebratorium (tb). (B - J) Immunolocalization of activated p38 MAPK (green) in S. mansoni miracidia following fixing and staining of parasites with anti-phospho p38 MAPK primary antibodies. (B) Freshly-hatched miracidium incubated without primary antibodies but with secondary antibodies alone (negative control). (C) Freshly-hatched swimming miracidium displaying weak patchy staining only localized adjacent to the tegument (tg) in areas corresponding to the cilia. (D) Serial optical z-section of a miracidium treated with 20 μM anisomycin for 30 min showing p38 MAPK activity in the regions occupied by cilia. (E and F) High power, optically zoomed, z-sections through discrete regions of cilia/tegument to capture the miracidium surface in one plane with (E) showing p38 MAPK localized to the shafts of the cilia (arrowed) and regions proximal to the tegument, and (F) showing co-localization with cilia (red) detected using anti-acetylated tubulin antibodies. (G) Miracidium treated with 20 μM anisomycin for 30 min for direct comparison with (C). (H) Autofluorescence (red) of S. mansoni egg containing (I, and J overlay) miracidium (m) with p38 MAPK activity in regions occupied by cilia. (K) Scanning electron micrograph of S. mansoni egg revealing common position of rupture during hatching, and correlating to rupture in H-J. Z-axis projections are shown in maximum pixel brightness mode. Bars: A, E and F = 2 μm; B-D, and G = 15 μm; H-K = 25 μm.

    Techniques Used: Staining, Incubation, Negative Control, Activity Assay

    p38 MAPK activation and inhibition affects S. mansoni miracidia swim velocity . Freshly-hatched swimming miracidia were collected and incubated with (A) SB 203580 (1 μM) or (B) anisomycin (20 μM) in spring water, or spring water alone, and the effects on miracidia swim behaviour over 60 min captured by digital video microscopy. Calculation of swim velocities (mm/s) for 30 miracidia for each treatment and each time point was achieved using ImageJ and mean swim speeds (± SEM) were calculated. * P ≤ 0.05, ** P ≤ 0.01, and *** P ≤ 0.001.
    Figure Legend Snippet: p38 MAPK activation and inhibition affects S. mansoni miracidia swim velocity . Freshly-hatched swimming miracidia were collected and incubated with (A) SB 203580 (1 μM) or (B) anisomycin (20 μM) in spring water, or spring water alone, and the effects on miracidia swim behaviour over 60 min captured by digital video microscopy. Calculation of swim velocities (mm/s) for 30 miracidia for each treatment and each time point was achieved using ImageJ and mean swim speeds (± SEM) were calculated. * P ≤ 0.05, ** P ≤ 0.01, and *** P ≤ 0.001.

    Techniques Used: Activation Assay, Inhibition, Incubation, Microscopy

    p38 MAPK activation accelerates the liberation of ciliated plates in transforming S. mansoni larvae . Cultures of larvae were exposed to (A) SB 203580 or (B) anisomycin, during transformation in vitro and the proportion of fully-ciliated parasites determined by microscopic examination over 50 h, compared to CBSS controls. Values shown are means (± SEM, n = 90 for each time point and each treatment from three independent experiments). *P ≤ 0.05, ** P ≤ 0.01, and *** P ≤ 0.001.
    Figure Legend Snippet: p38 MAPK activation accelerates the liberation of ciliated plates in transforming S. mansoni larvae . Cultures of larvae were exposed to (A) SB 203580 or (B) anisomycin, during transformation in vitro and the proportion of fully-ciliated parasites determined by microscopic examination over 50 h, compared to CBSS controls. Values shown are means (± SEM, n = 90 for each time point and each treatment from three independent experiments). *P ≤ 0.05, ** P ≤ 0.01, and *** P ≤ 0.001.

    Techniques Used: Activation Assay, Transformation Assay, In Vitro

    anisomycin  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Cell Signaling Technology Inc anisomycin
    EpCAM expression is associated with phosphorylation of the AP-1 transcription factor protein subunit c-Jun . (a) Specific ablation of epithelial cell adhesion molecule (EpCAM) is associated with decreased c-Jun phosphorylation as measured by multiplex phosphoprotein assay. Stably transduced CA1a cells (scrambled control shRNA construct (SCR) and sh2) were induced with epidermal growth factor (EGF), and phosphorylation was measured using a multiplex phosphoprotein assay. Relative levels of phosphorylated (p)-AKT, p-c-Jun, and p-JNK were measured by flow cytometry and expressed as mean fluorescence intensity (MFI). Error bars represent standard error. (b) Specific ablation of EpCAM is associated with decreased c-Jun phosphorylation as measured by phosphoprotein immunoblot. Stably transduced CA1a and MCF-7 cells (SCR and sh2) were serum-starved for six hours. The cells were treated with 20 μM <t>anisomycin</t> for 15 minutes and 30 μg of the cell lysate was analyzed with antibodies recognizing EpCAM, superoxide dismutase (SOD, loading control), p-c-Jun-63, or total c-Jun. Relative band density was quantified using ImageJ software, with the results indicated below the relevant band. (c) Recombinant EpCAM is capable of rescuing c-Jun phosphorylation in CA1a(sh2) cells. CA1a(sh2) cells were serum-starved for six hours and then treated with rEpCAM at concentrations of 50, 100, and 200 ng/mL for two hours. The cells were then stimulated with anisomycin for 10 minutes. A 30 μg sample of each cell lysate was analyzed for p-c-Jun and total c-Jun. Relative band density was quantified using ImageJ software, with the results indicated. The results are representative of two independent experiments.
    Anisomycin, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anisomycin/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anisomycin - by Bioz Stars, 2023-03
    86/100 stars

    Images

    1) Product Images from "Activator protein 1 (AP-1) contributes to EpCAM-dependent breast cancer invasion"

    Article Title: Activator protein 1 (AP-1) contributes to EpCAM-dependent breast cancer invasion

    Journal: Breast Cancer Research : BCR

    doi: 10.1186/bcr3070

    EpCAM expression is associated with phosphorylation of the AP-1 transcription factor protein subunit c-Jun . (a) Specific ablation of epithelial cell adhesion molecule (EpCAM) is associated with decreased c-Jun phosphorylation as measured by multiplex phosphoprotein assay. Stably transduced CA1a cells (scrambled control shRNA construct (SCR) and sh2) were induced with epidermal growth factor (EGF), and phosphorylation was measured using a multiplex phosphoprotein assay. Relative levels of phosphorylated (p)-AKT, p-c-Jun, and p-JNK were measured by flow cytometry and expressed as mean fluorescence intensity (MFI). Error bars represent standard error. (b) Specific ablation of EpCAM is associated with decreased c-Jun phosphorylation as measured by phosphoprotein immunoblot. Stably transduced CA1a and MCF-7 cells (SCR and sh2) were serum-starved for six hours. The cells were treated with 20 μM anisomycin for 15 minutes and 30 μg of the cell lysate was analyzed with antibodies recognizing EpCAM, superoxide dismutase (SOD, loading control), p-c-Jun-63, or total c-Jun. Relative band density was quantified using ImageJ software, with the results indicated below the relevant band. (c) Recombinant EpCAM is capable of rescuing c-Jun phosphorylation in CA1a(sh2) cells. CA1a(sh2) cells were serum-starved for six hours and then treated with rEpCAM at concentrations of 50, 100, and 200 ng/mL for two hours. The cells were then stimulated with anisomycin for 10 minutes. A 30 μg sample of each cell lysate was analyzed for p-c-Jun and total c-Jun. Relative band density was quantified using ImageJ software, with the results indicated. The results are representative of two independent experiments.
    Figure Legend Snippet: EpCAM expression is associated with phosphorylation of the AP-1 transcription factor protein subunit c-Jun . (a) Specific ablation of epithelial cell adhesion molecule (EpCAM) is associated with decreased c-Jun phosphorylation as measured by multiplex phosphoprotein assay. Stably transduced CA1a cells (scrambled control shRNA construct (SCR) and sh2) were induced with epidermal growth factor (EGF), and phosphorylation was measured using a multiplex phosphoprotein assay. Relative levels of phosphorylated (p)-AKT, p-c-Jun, and p-JNK were measured by flow cytometry and expressed as mean fluorescence intensity (MFI). Error bars represent standard error. (b) Specific ablation of EpCAM is associated with decreased c-Jun phosphorylation as measured by phosphoprotein immunoblot. Stably transduced CA1a and MCF-7 cells (SCR and sh2) were serum-starved for six hours. The cells were treated with 20 μM anisomycin for 15 minutes and 30 μg of the cell lysate was analyzed with antibodies recognizing EpCAM, superoxide dismutase (SOD, loading control), p-c-Jun-63, or total c-Jun. Relative band density was quantified using ImageJ software, with the results indicated below the relevant band. (c) Recombinant EpCAM is capable of rescuing c-Jun phosphorylation in CA1a(sh2) cells. CA1a(sh2) cells were serum-starved for six hours and then treated with rEpCAM at concentrations of 50, 100, and 200 ng/mL for two hours. The cells were then stimulated with anisomycin for 10 minutes. A 30 μg sample of each cell lysate was analyzed for p-c-Jun and total c-Jun. Relative band density was quantified using ImageJ software, with the results indicated. The results are representative of two independent experiments.

    Techniques Used: Expressing, Multiplex Assay, Stable Transfection, shRNA, Construct, Flow Cytometry, Fluorescence, Western Blot, Software, Recombinant

    The MEKK1/MKK7/JNK signal transduction pathway contributes to EpCAM-dependent AP-1 transcription factor activity . (a) Pharmacologic inhibition of c-Jun N-terminal kinase (JNK) abrogates recombinant soluble extracellular epithelial cell adhesion molecule (rEpCAM)-mediated rescue of activator protein 1 (AP-1) transcription factor activity. Stably transduced CA1a (scrambled control shRNA construct (SCR) and sh2) cells were transiently transfected with AP-1 and control luciferase reporters. Six hours after transfection, cells were treated with SP600125 (JNK inhibitor) at 10 μM and 20 μM for one hour followed by addition of rEpCAM. Luciferase reporter activity was measured 16 hours later. (b) To directly evaluate JNK phosphorylation, SCR and sh2 CA1a and MCF-7 cells were serum starved for 12 hours, stimulated with 20 μM anisomycin for 10 minutes, and then immunoprecipitated overnight with a JNK antibody. JNK phosphorylation was evaluated by immunoblot using antibodies specific for p-JNK1/2 and total JNK1. Relative band density was quantified using ImageJ software, with the results indicated. (c) Constitutively active genetic constructs corresponding to mitogen activated protein (MAP) kinases in the JNK signal transduction pathway rescued c-Jun phosphorylation and AP-1 transcription factor activity following specific ablation of EpCAM in MCF-7 breast cancer cells. Stably transduced SCR or sh2 MCF-7 cells were transiently transfected with plasmids encoding HA-MEKK1, FLAG-MKK7-JNK1, FLAG-MKK7, and FLAG-JNK1. After 16 hours, cells were analyzed by immunoblot for c-Jun phosphorylation. Relative band density was quantified using ImageJ software, with the results indicated. (d) Duplicate samples were transiently transfected with control and AP-1 luciferase reporters, and AP-1 transcription factor activity was measured. (e) Expression of HA-MEKK1, FLAG-MKK7-JNK1, FLAG-MKK7, and FLAG-JNK1 was confirmed by immunoblot with antibodies specific for the indicated protein tag (HA or FLAG). The results are representative of two independent experiments. For AP-1 reporter assay in Figure a and d, P < 0.05 were considered to be statistically significant when compared between SCR, sh2 (*) and sh2, sh2 treated/transfected cells (**).
    Figure Legend Snippet: The MEKK1/MKK7/JNK signal transduction pathway contributes to EpCAM-dependent AP-1 transcription factor activity . (a) Pharmacologic inhibition of c-Jun N-terminal kinase (JNK) abrogates recombinant soluble extracellular epithelial cell adhesion molecule (rEpCAM)-mediated rescue of activator protein 1 (AP-1) transcription factor activity. Stably transduced CA1a (scrambled control shRNA construct (SCR) and sh2) cells were transiently transfected with AP-1 and control luciferase reporters. Six hours after transfection, cells were treated with SP600125 (JNK inhibitor) at 10 μM and 20 μM for one hour followed by addition of rEpCAM. Luciferase reporter activity was measured 16 hours later. (b) To directly evaluate JNK phosphorylation, SCR and sh2 CA1a and MCF-7 cells were serum starved for 12 hours, stimulated with 20 μM anisomycin for 10 minutes, and then immunoprecipitated overnight with a JNK antibody. JNK phosphorylation was evaluated by immunoblot using antibodies specific for p-JNK1/2 and total JNK1. Relative band density was quantified using ImageJ software, with the results indicated. (c) Constitutively active genetic constructs corresponding to mitogen activated protein (MAP) kinases in the JNK signal transduction pathway rescued c-Jun phosphorylation and AP-1 transcription factor activity following specific ablation of EpCAM in MCF-7 breast cancer cells. Stably transduced SCR or sh2 MCF-7 cells were transiently transfected with plasmids encoding HA-MEKK1, FLAG-MKK7-JNK1, FLAG-MKK7, and FLAG-JNK1. After 16 hours, cells were analyzed by immunoblot for c-Jun phosphorylation. Relative band density was quantified using ImageJ software, with the results indicated. (d) Duplicate samples were transiently transfected with control and AP-1 luciferase reporters, and AP-1 transcription factor activity was measured. (e) Expression of HA-MEKK1, FLAG-MKK7-JNK1, FLAG-MKK7, and FLAG-JNK1 was confirmed by immunoblot with antibodies specific for the indicated protein tag (HA or FLAG). The results are representative of two independent experiments. For AP-1 reporter assay in Figure a and d, P < 0.05 were considered to be statistically significant when compared between SCR, sh2 (*) and sh2, sh2 treated/transfected cells (**).

    Techniques Used: Transduction, Activity Assay, Inhibition, Recombinant, Stable Transfection, shRNA, Construct, Transfection, Luciferase, Immunoprecipitation, Western Blot, Software, Expressing, Reporter Assay

    p38 agonist anisomycin  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Cell Signaling Technology Inc p38 agonist anisomycin
    The effects of the reagents on CCD-induced mechanical allodynia. (a–d) The PWMTs of CCD rats (4 days after operation) 1, 2, 4, and 8 h after RR, 4 α -PDD, SB203580, and <t>anisomycin</t> intrathecal injections ( n = 6; the data are expressed as means ± SEMs); ∗ P < 0.05 and ∗∗ P < 0.01 compared ipsilaterally with the saline group; one-way ANOVA followed by Tukey's post hoc test.
    P38 Agonist Anisomycin, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/p38 agonist anisomycin/product/Cell Signaling Technology Inc
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    p38 agonist anisomycin - by Bioz Stars, 2023-03
    93/100 stars

    Images

    1) Product Images from "Effect of TRPV4-p38 MAPK Pathway on Neuropathic Pain in Rats with Chronic Compression of the Dorsal Root Ganglion"

    Article Title: Effect of TRPV4-p38 MAPK Pathway on Neuropathic Pain in Rats with Chronic Compression of the Dorsal Root Ganglion

    Journal: BioMed Research International

    doi: 10.1155/2016/6978923

    The effects of the reagents on CCD-induced mechanical allodynia. (a–d) The PWMTs of CCD rats (4 days after operation) 1, 2, 4, and 8 h after RR, 4 α -PDD, SB203580, and anisomycin intrathecal injections ( n = 6; the data are expressed as means ± SEMs); ∗ P < 0.05 and ∗∗ P < 0.01 compared ipsilaterally with the saline group; one-way ANOVA followed by Tukey's post hoc test.
    Figure Legend Snippet: The effects of the reagents on CCD-induced mechanical allodynia. (a–d) The PWMTs of CCD rats (4 days after operation) 1, 2, 4, and 8 h after RR, 4 α -PDD, SB203580, and anisomycin intrathecal injections ( n = 6; the data are expressed as means ± SEMs); ∗ P < 0.05 and ∗∗ P < 0.01 compared ipsilaterally with the saline group; one-way ANOVA followed by Tukey's post hoc test.

    Techniques Used:

    Distribution changes of the p38-positive neurons in DRG tissue. (a–f) p38 immunohistochemical staining of the DRG neurons in the control, CCD, CCD+RR 10 nmol/L, CCD+4 α -PDD 10 nmol/L, CCD+SB203580 20 μ mol/L, and CCD+anisomycin 25 μ g/mL groups. Scale bars: 100 μ m. (g) The analysis of the p38-positive neurons (shown as means ± SEMs); ∗ P < 0.05 and ∗∗ P < 0.01 compared with controls; ## P < 0.01 compared with the CCD group.
    Figure Legend Snippet: Distribution changes of the p38-positive neurons in DRG tissue. (a–f) p38 immunohistochemical staining of the DRG neurons in the control, CCD, CCD+RR 10 nmol/L, CCD+4 α -PDD 10 nmol/L, CCD+SB203580 20 μ mol/L, and CCD+anisomycin 25 μ g/mL groups. Scale bars: 100 μ m. (g) The analysis of the p38-positive neurons (shown as means ± SEMs); ∗ P < 0.05 and ∗∗ P < 0.01 compared with controls; ## P < 0.01 compared with the CCD group.

    Techniques Used: Immunohistochemical staining, Staining

    The effect of reagents on the protein expression of TRPV4, p38, and P-p38. (a–d) The expression of TRPV4, p38, and P-p38 proteins after RR, 4 α -PDD, SB203580, and anisomycin intrathecal injections given to rats 4 days after CCD surgery. The bars represent means ± SEMs based on six experiments; ∗ P < 0.05 and ∗∗ P < 0.01, TRPV4 compared with controls. # P < 0.05 and ## P < 0.01, p38 compared with controls. & P < 0.05 and && P < 0.01, P-p38 compared with controls.
    Figure Legend Snippet: The effect of reagents on the protein expression of TRPV4, p38, and P-p38. (a–d) The expression of TRPV4, p38, and P-p38 proteins after RR, 4 α -PDD, SB203580, and anisomycin intrathecal injections given to rats 4 days after CCD surgery. The bars represent means ± SEMs based on six experiments; ∗ P < 0.05 and ∗∗ P < 0.01, TRPV4 compared with controls. # P < 0.05 and ## P < 0.01, p38 compared with controls. & P < 0.05 and && P < 0.01, P-p38 compared with controls.

    Techniques Used: Expressing

    Altered distribution of TRPV4-positive neurons in DRG tissue. (a–f) TRPV4 immunohistochemical staining of the DRG neurons in the control, CCD, CCD+RR 10 nmol/L, CCD+4 α -PDD 10 nmol/L, CCD+SB203580 20 μ mol/L, and CCD+anisomycin 25 μ g/mL groups, respectively. Scale bars: 100 μ m. (g) The analysis of the TRPV4-positive neurons (shown as means ± SEMs); ∗∗ P < 0.01 compared with controls; ## P < 0.01 compared with the CCD group.
    Figure Legend Snippet: Altered distribution of TRPV4-positive neurons in DRG tissue. (a–f) TRPV4 immunohistochemical staining of the DRG neurons in the control, CCD, CCD+RR 10 nmol/L, CCD+4 α -PDD 10 nmol/L, CCD+SB203580 20 μ mol/L, and CCD+anisomycin 25 μ g/mL groups, respectively. Scale bars: 100 μ m. (g) The analysis of the TRPV4-positive neurons (shown as means ± SEMs); ∗∗ P < 0.01 compared with controls; ## P < 0.01 compared with the CCD group.

    Techniques Used: Immunohistochemical staining, Staining

    Ectopic discharges after CCD surgery and reagent injection. (a–f) represent discharges of the control, CCD, CCD+RR 10 nmol/L, CCD+4 α -PDD 10 nmol/L, CCD+SB203580 20 μ mol/L, and CCD+anisomycin 25 μ g/mL groups. Cut from BL-420E+ biological and functional experimental system. (g) and (h) show the amplitudes and frequencies for the different groups (data are expressed as means ± SEM); ∗∗ P < 0.01, compared with the CCD group (7-8 rats in each group).
    Figure Legend Snippet: Ectopic discharges after CCD surgery and reagent injection. (a–f) represent discharges of the control, CCD, CCD+RR 10 nmol/L, CCD+4 α -PDD 10 nmol/L, CCD+SB203580 20 μ mol/L, and CCD+anisomycin 25 μ g/mL groups. Cut from BL-420E+ biological and functional experimental system. (g) and (h) show the amplitudes and frequencies for the different groups (data are expressed as means ± SEM); ∗∗ P < 0.01, compared with the CCD group (7-8 rats in each group).

    Techniques Used: Injection, Functional Assay

    gpx4  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Cell Signaling Technology Inc gpx4
    Effect of HMSeBA supplementation on the expression of selenoproteins and the antioxidative capacity in IPEC-J2 cells. IPEC-J2 cells were treated with 1.2 μM HMSeBA for 24 h. (A) Relative mRNA levels of selenoproteins. n = 3 for each group. (B) Relative protein abundance of <t>GPX4,</t> SELENOS and SELENOP. n = 4 for each group. (C) The activity of antioxidant related enzymes. n = 6 for each group. GSH-Px, glutathione peroxidase; T-SOD, total superoxide dismutase; CAT, catalase; T-AOC, total antioxidant capacity. Data are expressed as mean ± SE. * P < 0.05, ** P < 0.01, *** P < 0.001.
    Gpx4, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gpx4/product/Cell Signaling Technology Inc
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    gpx4 - by Bioz Stars, 2023-03
    93/100 stars

    Images

    1) Product Images from "Maternal Organic Selenium Supplementation Relieves Intestinal Endoplasmic Reticulum Stress in Piglets by Enhancing the Expression of Glutathione Peroxidase 4 and Selenoprotein S"

    Article Title: Maternal Organic Selenium Supplementation Relieves Intestinal Endoplasmic Reticulum Stress in Piglets by Enhancing the Expression of Glutathione Peroxidase 4 and Selenoprotein S

    Journal: Frontiers in Nutrition

    doi: 10.3389/fnut.2022.900421

    Effect of HMSeBA supplementation on the expression of selenoproteins and the antioxidative capacity in IPEC-J2 cells. IPEC-J2 cells were treated with 1.2 μM HMSeBA for 24 h. (A) Relative mRNA levels of selenoproteins. n = 3 for each group. (B) Relative protein abundance of GPX4, SELENOS and SELENOP. n = 4 for each group. (C) The activity of antioxidant related enzymes. n = 6 for each group. GSH-Px, glutathione peroxidase; T-SOD, total superoxide dismutase; CAT, catalase; T-AOC, total antioxidant capacity. Data are expressed as mean ± SE. * P < 0.05, ** P < 0.01, *** P < 0.001.
    Figure Legend Snippet: Effect of HMSeBA supplementation on the expression of selenoproteins and the antioxidative capacity in IPEC-J2 cells. IPEC-J2 cells were treated with 1.2 μM HMSeBA for 24 h. (A) Relative mRNA levels of selenoproteins. n = 3 for each group. (B) Relative protein abundance of GPX4, SELENOS and SELENOP. n = 4 for each group. (C) The activity of antioxidant related enzymes. n = 6 for each group. GSH-Px, glutathione peroxidase; T-SOD, total superoxide dismutase; CAT, catalase; T-AOC, total antioxidant capacity. Data are expressed as mean ± SE. * P < 0.05, ** P < 0.01, *** P < 0.001.

    Techniques Used: Expressing, Activity Assay

    Roles of GPX4 and SELENOS in regulating ER stress induced by H 2 O 2 in IPEC-J2 cells. (A) IPEC-J2 cells were infected with AdshGPX4, then were treated with H 2 O 2 plus HMSeBA. Protein levels of ER stress related markers were detected. (B) IPEC-J2 cells were infected with AdshSELS, then were treated with H 2 O 2 plus HMSeBA. Protein levels of ER stress related markers were detected. (C) IPEC-J2 cells were infected with AdshGPX4 or/and AdshSELS, then were treated with H 2 O 2 . Protein levels of ER stress related markers were detected n = 4 or 3 for western blot assay. Data are expressed as mean ± SE. * P < 0.05, ** P < 0.01, *** P < 0.001.
    Figure Legend Snippet: Roles of GPX4 and SELENOS in regulating ER stress induced by H 2 O 2 in IPEC-J2 cells. (A) IPEC-J2 cells were infected with AdshGPX4, then were treated with H 2 O 2 plus HMSeBA. Protein levels of ER stress related markers were detected. (B) IPEC-J2 cells were infected with AdshSELS, then were treated with H 2 O 2 plus HMSeBA. Protein levels of ER stress related markers were detected. (C) IPEC-J2 cells were infected with AdshGPX4 or/and AdshSELS, then were treated with H 2 O 2 . Protein levels of ER stress related markers were detected n = 4 or 3 for western blot assay. Data are expressed as mean ± SE. * P < 0.05, ** P < 0.01, *** P < 0.001.

    Techniques Used: Infection, Western Blot

    General view of the effect of HMSeBA on intestinal ER stress. A model for HMSeBA supplementation regulates ER stress induced by LPS or H 2 O 2 in vivo and vitro . Only core components of the pathway are shown. LPS or H 2 O 2 administration induce ER stress through activating the GRP78-IRE1α-CHOP signaling pathway. While HMSeBA treatment improves the expression of GPX4 and SELS, thereby suppresses the ER stress signal, ameliorates the redox status. Maternal HMSeBA is involved in regulating the ER stress signal and health of intestine.
    Figure Legend Snippet: General view of the effect of HMSeBA on intestinal ER stress. A model for HMSeBA supplementation regulates ER stress induced by LPS or H 2 O 2 in vivo and vitro . Only core components of the pathway are shown. LPS or H 2 O 2 administration induce ER stress through activating the GRP78-IRE1α-CHOP signaling pathway. While HMSeBA treatment improves the expression of GPX4 and SELS, thereby suppresses the ER stress signal, ameliorates the redox status. Maternal HMSeBA is involved in regulating the ER stress signal and health of intestine.

    Techniques Used: In Vivo, Expressing

    myogenic colonic slow transmission  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Cell Signaling Technology Inc myogenic colonic slow transmission
    Myogenic Colonic Slow Transmission, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/myogenic colonic slow transmission/product/Cell Signaling Technology Inc
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    myogenic colonic slow transmission - by Bioz Stars, 2023-03
    93/100 stars

    Images

    Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93
    Cell Signaling Technology Inc anisomycin
    Dioscin inhibits macrophages and fibroblasts from secreting pro-inflammatory cytokines. (A) Western blot analyses of ASK1 phosphorylation and downstream MAPK proteins (p38 and JNK/SAPK) in LPS-primed RAW 264.7 macrophages treated with CS (50 μg/cm 2 ) together with different does of dioscin for 6 h. <t>Anisomycin</t> was used to reverse dioscin's effect (2 ng/mL). Quantification of each protein level relative to β-Actin is shown below each band . (B-D) The levels of phospho-ASK1, phospho-p38 and phosphor-JNK were normalized to those of β-Actin (n=3). (E-H) ELISA analyses of pro-inflammation cytokines in the culture medium of different treated macrophages at 6 h. (E) MCP-1, (F) IL-1β, (G) IL-6, (H)TNF-α (n=3). Data are the mean of three independent experiments (n=3). (I) Western blot analyses of ASK1 phosphorylation and downstream MAPK proteins (p38 and JNK/SAPK) in TNF-α- (25 ng/mL) treated NIH-3T3 fibroblasts together with different does of dioscin for 30 min. Quantification of each protein level relative to β-Actin is shown below each band . (J-L) The levels of phospho-ASK1, phospho-p38 and phosphor-JNK were normalized to those of β-Actin (n=3). (M) qPCR analysis of Il-6 mRNA levels in TNF-α- (25 ng/mL) treated fibroblasts together with different concentrations of dioscin for 12 h (n=3). *, P<0.05; **, P<0.01. Error bars indicate the mean ± SD. The experiment was performed twice with similar results.
    Anisomycin, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anisomycin/product/Cell Signaling Technology Inc
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anisomycin - by Bioz Stars, 2023-03
    93/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc anisomycin treated c6 cell extracts
    Dioscin inhibits macrophages and fibroblasts from secreting pro-inflammatory cytokines. (A) Western blot analyses of ASK1 phosphorylation and downstream MAPK proteins (p38 and JNK/SAPK) in LPS-primed RAW 264.7 macrophages treated with CS (50 μg/cm 2 ) together with different does of dioscin for 6 h. <t>Anisomycin</t> was used to reverse dioscin's effect (2 ng/mL). Quantification of each protein level relative to β-Actin is shown below each band . (B-D) The levels of phospho-ASK1, phospho-p38 and phosphor-JNK were normalized to those of β-Actin (n=3). (E-H) ELISA analyses of pro-inflammation cytokines in the culture medium of different treated macrophages at 6 h. (E) MCP-1, (F) IL-1β, (G) IL-6, (H)TNF-α (n=3). Data are the mean of three independent experiments (n=3). (I) Western blot analyses of ASK1 phosphorylation and downstream MAPK proteins (p38 and JNK/SAPK) in TNF-α- (25 ng/mL) treated NIH-3T3 fibroblasts together with different does of dioscin for 30 min. Quantification of each protein level relative to β-Actin is shown below each band . (J-L) The levels of phospho-ASK1, phospho-p38 and phosphor-JNK were normalized to those of β-Actin (n=3). (M) qPCR analysis of Il-6 mRNA levels in TNF-α- (25 ng/mL) treated fibroblasts together with different concentrations of dioscin for 12 h (n=3). *, P<0.05; **, P<0.01. Error bars indicate the mean ± SD. The experiment was performed twice with similar results.
    Anisomycin Treated C6 Cell Extracts, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anisomycin treated c6 cell extracts/product/Cell Signaling Technology Inc
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anisomycin treated c6 cell extracts - by Bioz Stars, 2023-03
    93/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc p38 mapk activator anisomycin
    Sequence alignment and domain analysis of S. mansoni <t>p38</t> <t>MAPK</t> . The S. mansoni putative <t>p38</t> <t>MAPK</t> sequence (XP_002571000) was aligned with those for S. japonicum MAPK14a, Homo sapiens (p38 MAPKα, also known as MAPK14 isoform 1), Drosophila melanogaster (p38a MAPK and p38b MAPK), Caenorhabditis elegans (p38 MAPK family member, PMK1) and Danio rerio (MAPK 14a); accession numbers are shown. Multiple alignments were achieved using Geneious Pro 4.85 with Blosum62 cost matrix and default settings; shading of residues: black = 100% similar, dark grey = 80-100% similar, light grey = 60-80% similar and white < 60% similar. The ATP binding site, kinase interacting motif (KIM) docking site, and activation loop are indicated by coloured arrows. Within the activation loop, the conserved Thr-Gly-Tyr (TGY) phosphorylation motif is highlighted by the yellow box, with the phosphorylated residues (Thr and Tyr) central to kinase activation indicated with green asterisks; the substrate binding site is shown by the orange box. Sequence highlighted by the blue box is that used to generate the monoclonal anti-phospho p38 MAPK antibodies. The residues within the ATP binding site that are known to confer specificity and sensitivity of SB 230580 towards p38 MAPK are highlighted by the red box with the residue (Thr) most responsible for p38 MAPK inhibition indicated by the red asterisk; red crosses denote other known interaction sites between SB 203580 and p38 MAPK (see text for further details).
    P38 Mapk Activator Anisomycin, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/p38 mapk activator anisomycin/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    p38 mapk activator anisomycin - by Bioz Stars, 2023-03
    86/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc p38 agonist anisomycin
    The effects of the reagents on CCD-induced mechanical allodynia. (a–d) The PWMTs of CCD rats (4 days after operation) 1, 2, 4, and 8 h after RR, 4 α -PDD, SB203580, and <t>anisomycin</t> intrathecal injections ( n = 6; the data are expressed as means ± SEMs); ∗ P < 0.05 and ∗∗ P < 0.01 compared ipsilaterally with the saline group; one-way ANOVA followed by Tukey's post hoc test.
    P38 Agonist Anisomycin, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/p38 agonist anisomycin/product/Cell Signaling Technology Inc
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    p38 agonist anisomycin - by Bioz Stars, 2023-03
    93/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc gpx4
    Effect of HMSeBA supplementation on the expression of selenoproteins and the antioxidative capacity in IPEC-J2 cells. IPEC-J2 cells were treated with 1.2 μM HMSeBA for 24 h. (A) Relative mRNA levels of selenoproteins. n = 3 for each group. (B) Relative protein abundance of <t>GPX4,</t> SELENOS and SELENOP. n = 4 for each group. (C) The activity of antioxidant related enzymes. n = 6 for each group. GSH-Px, glutathione peroxidase; T-SOD, total superoxide dismutase; CAT, catalase; T-AOC, total antioxidant capacity. Data are expressed as mean ± SE. * P < 0.05, ** P < 0.01, *** P < 0.001.
    Gpx4, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gpx4/product/Cell Signaling Technology Inc
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    gpx4 - by Bioz Stars, 2023-03
    93/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc myogenic colonic slow transmission
    Effect of HMSeBA supplementation on the expression of selenoproteins and the antioxidative capacity in IPEC-J2 cells. IPEC-J2 cells were treated with 1.2 μM HMSeBA for 24 h. (A) Relative mRNA levels of selenoproteins. n = 3 for each group. (B) Relative protein abundance of <t>GPX4,</t> SELENOS and SELENOP. n = 4 for each group. (C) The activity of antioxidant related enzymes. n = 6 for each group. GSH-Px, glutathione peroxidase; T-SOD, total superoxide dismutase; CAT, catalase; T-AOC, total antioxidant capacity. Data are expressed as mean ± SE. * P < 0.05, ** P < 0.01, *** P < 0.001.
    Myogenic Colonic Slow Transmission, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/myogenic colonic slow transmission/product/Cell Signaling Technology Inc
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    myogenic colonic slow transmission - by Bioz Stars, 2023-03
    93/100 stars
      Buy from Supplier

    Image Search Results


    Dioscin inhibits macrophages and fibroblasts from secreting pro-inflammatory cytokines. (A) Western blot analyses of ASK1 phosphorylation and downstream MAPK proteins (p38 and JNK/SAPK) in LPS-primed RAW 264.7 macrophages treated with CS (50 μg/cm 2 ) together with different does of dioscin for 6 h. Anisomycin was used to reverse dioscin's effect (2 ng/mL). Quantification of each protein level relative to β-Actin is shown below each band . (B-D) The levels of phospho-ASK1, phospho-p38 and phosphor-JNK were normalized to those of β-Actin (n=3). (E-H) ELISA analyses of pro-inflammation cytokines in the culture medium of different treated macrophages at 6 h. (E) MCP-1, (F) IL-1β, (G) IL-6, (H)TNF-α (n=3). Data are the mean of three independent experiments (n=3). (I) Western blot analyses of ASK1 phosphorylation and downstream MAPK proteins (p38 and JNK/SAPK) in TNF-α- (25 ng/mL) treated NIH-3T3 fibroblasts together with different does of dioscin for 30 min. Quantification of each protein level relative to β-Actin is shown below each band . (J-L) The levels of phospho-ASK1, phospho-p38 and phosphor-JNK were normalized to those of β-Actin (n=3). (M) qPCR analysis of Il-6 mRNA levels in TNF-α- (25 ng/mL) treated fibroblasts together with different concentrations of dioscin for 12 h (n=3). *, P<0.05; **, P<0.01. Error bars indicate the mean ± SD. The experiment was performed twice with similar results.

    Journal: Theranostics

    Article Title: Dioscin Exerts Protective Effects Against Crystalline Silica-induced Pulmonary Fibrosis in Mice

    doi: 10.7150/thno.20270

    Figure Lengend Snippet: Dioscin inhibits macrophages and fibroblasts from secreting pro-inflammatory cytokines. (A) Western blot analyses of ASK1 phosphorylation and downstream MAPK proteins (p38 and JNK/SAPK) in LPS-primed RAW 264.7 macrophages treated with CS (50 μg/cm 2 ) together with different does of dioscin for 6 h. Anisomycin was used to reverse dioscin's effect (2 ng/mL). Quantification of each protein level relative to β-Actin is shown below each band . (B-D) The levels of phospho-ASK1, phospho-p38 and phosphor-JNK were normalized to those of β-Actin (n=3). (E-H) ELISA analyses of pro-inflammation cytokines in the culture medium of different treated macrophages at 6 h. (E) MCP-1, (F) IL-1β, (G) IL-6, (H)TNF-α (n=3). Data are the mean of three independent experiments (n=3). (I) Western blot analyses of ASK1 phosphorylation and downstream MAPK proteins (p38 and JNK/SAPK) in TNF-α- (25 ng/mL) treated NIH-3T3 fibroblasts together with different does of dioscin for 30 min. Quantification of each protein level relative to β-Actin is shown below each band . (J-L) The levels of phospho-ASK1, phospho-p38 and phosphor-JNK were normalized to those of β-Actin (n=3). (M) qPCR analysis of Il-6 mRNA levels in TNF-α- (25 ng/mL) treated fibroblasts together with different concentrations of dioscin for 12 h (n=3). *, P<0.05; **, P<0.01. Error bars indicate the mean ± SD. The experiment was performed twice with similar results.

    Article Snippet: Anisomycin (2 ng/mL, Cell Signaling Technology), activator of JNK and p38 MAPKs, was used to test the biological effect of dioscin on the MAPKs.

    Techniques: Western Blot, Enzyme-linked Immunosorbent Assay

    Dioscin regulated the TGF-β1-Samd3 signaling pathway and regulatory T cell functions. (A, B) Western blot analysis and quantification of TGF-β1 in lungs of dioscin-treated mice at 56 d (n=3). β-Actin was used as the loading control. Quantification of TGF-β1 levels relative to β-Actin is shown below the band. (C) qPCR analysis of Tgf-β1 in the lung tissues (n=6-8 per group). *, P<0.05; **, P<0.01. Error bars indicate the mean ± SD. The experiment was performed in triplicate. (D, E) Western blot analysis and quantification of Smad3 signaling in the lungs of treated mice at 56 d (n=3). β-Actin was used as the loading control. Quantification of p-Smad3 levels relative to β-Actin is shown below the band. (F, G) Western blot analysis of p-Smad3 and Smad3 in NIH-3T3 fibroblast, 30 min after TGF-β1 (5 ng/mL) and dioscin treatment. Quantification of p-Smad3 levels relative to β-Actin is shown below the band. (H) Schematic design of transwell experiment: RAW 264.7 macrophages were primed by LPS (25 ng/mL) for 3 h, and then treated with CS (50 μg/cm 2 ) together with dioscin or anisomycin (2 ng/mL) for 24 h in the lower plate, while NIH-3T3 fibroblasts were attached in the upper chamber. After that, the upper chamber was inserted back to the lower plate, and macrophages and fibroblasts were co-cultured for another 24 h. Then, the mRNA expressions of Col1a1 (I) and α-SMA (J) in NIH-3T3 fibroblast were determined by qPCR (n=3). (K, L) Percentage of CD4+CD25+FoxP3+ cells (regulatory T cells) in hilar lymph nodes was assayed by FACS analysis (n=5). *, P<0.05; **, P<0.01. Error bars indicate the mean ± SD.

    Journal: Theranostics

    Article Title: Dioscin Exerts Protective Effects Against Crystalline Silica-induced Pulmonary Fibrosis in Mice

    doi: 10.7150/thno.20270

    Figure Lengend Snippet: Dioscin regulated the TGF-β1-Samd3 signaling pathway and regulatory T cell functions. (A, B) Western blot analysis and quantification of TGF-β1 in lungs of dioscin-treated mice at 56 d (n=3). β-Actin was used as the loading control. Quantification of TGF-β1 levels relative to β-Actin is shown below the band. (C) qPCR analysis of Tgf-β1 in the lung tissues (n=6-8 per group). *, P<0.05; **, P<0.01. Error bars indicate the mean ± SD. The experiment was performed in triplicate. (D, E) Western blot analysis and quantification of Smad3 signaling in the lungs of treated mice at 56 d (n=3). β-Actin was used as the loading control. Quantification of p-Smad3 levels relative to β-Actin is shown below the band. (F, G) Western blot analysis of p-Smad3 and Smad3 in NIH-3T3 fibroblast, 30 min after TGF-β1 (5 ng/mL) and dioscin treatment. Quantification of p-Smad3 levels relative to β-Actin is shown below the band. (H) Schematic design of transwell experiment: RAW 264.7 macrophages were primed by LPS (25 ng/mL) for 3 h, and then treated with CS (50 μg/cm 2 ) together with dioscin or anisomycin (2 ng/mL) for 24 h in the lower plate, while NIH-3T3 fibroblasts were attached in the upper chamber. After that, the upper chamber was inserted back to the lower plate, and macrophages and fibroblasts were co-cultured for another 24 h. Then, the mRNA expressions of Col1a1 (I) and α-SMA (J) in NIH-3T3 fibroblast were determined by qPCR (n=3). (K, L) Percentage of CD4+CD25+FoxP3+ cells (regulatory T cells) in hilar lymph nodes was assayed by FACS analysis (n=5). *, P<0.05; **, P<0.01. Error bars indicate the mean ± SD.

    Article Snippet: Anisomycin (2 ng/mL, Cell Signaling Technology), activator of JNK and p38 MAPKs, was used to test the biological effect of dioscin on the MAPKs.

    Techniques: Western Blot, Cell Culture

    Sequence alignment and domain analysis of S. mansoni p38 MAPK . The S. mansoni putative p38 MAPK sequence (XP_002571000) was aligned with those for S. japonicum MAPK14a, Homo sapiens (p38 MAPKα, also known as MAPK14 isoform 1), Drosophila melanogaster (p38a MAPK and p38b MAPK), Caenorhabditis elegans (p38 MAPK family member, PMK1) and Danio rerio (MAPK 14a); accession numbers are shown. Multiple alignments were achieved using Geneious Pro 4.85 with Blosum62 cost matrix and default settings; shading of residues: black = 100% similar, dark grey = 80-100% similar, light grey = 60-80% similar and white < 60% similar. The ATP binding site, kinase interacting motif (KIM) docking site, and activation loop are indicated by coloured arrows. Within the activation loop, the conserved Thr-Gly-Tyr (TGY) phosphorylation motif is highlighted by the yellow box, with the phosphorylated residues (Thr and Tyr) central to kinase activation indicated with green asterisks; the substrate binding site is shown by the orange box. Sequence highlighted by the blue box is that used to generate the monoclonal anti-phospho p38 MAPK antibodies. The residues within the ATP binding site that are known to confer specificity and sensitivity of SB 230580 towards p38 MAPK are highlighted by the red box with the residue (Thr) most responsible for p38 MAPK inhibition indicated by the red asterisk; red crosses denote other known interaction sites between SB 203580 and p38 MAPK (see text for further details).

    Journal: BMC Cell Biology

    Article Title: A role for p38 MAPK in the regulation of ciliary motion in a eukaryote

    doi: 10.1186/1471-2121-12-6

    Figure Lengend Snippet: Sequence alignment and domain analysis of S. mansoni p38 MAPK . The S. mansoni putative p38 MAPK sequence (XP_002571000) was aligned with those for S. japonicum MAPK14a, Homo sapiens (p38 MAPKα, also known as MAPK14 isoform 1), Drosophila melanogaster (p38a MAPK and p38b MAPK), Caenorhabditis elegans (p38 MAPK family member, PMK1) and Danio rerio (MAPK 14a); accession numbers are shown. Multiple alignments were achieved using Geneious Pro 4.85 with Blosum62 cost matrix and default settings; shading of residues: black = 100% similar, dark grey = 80-100% similar, light grey = 60-80% similar and white < 60% similar. The ATP binding site, kinase interacting motif (KIM) docking site, and activation loop are indicated by coloured arrows. Within the activation loop, the conserved Thr-Gly-Tyr (TGY) phosphorylation motif is highlighted by the yellow box, with the phosphorylated residues (Thr and Tyr) central to kinase activation indicated with green asterisks; the substrate binding site is shown by the orange box. Sequence highlighted by the blue box is that used to generate the monoclonal anti-phospho p38 MAPK antibodies. The residues within the ATP binding site that are known to confer specificity and sensitivity of SB 230580 towards p38 MAPK are highlighted by the red box with the residue (Thr) most responsible for p38 MAPK inhibition indicated by the red asterisk; red crosses denote other known interaction sites between SB 203580 and p38 MAPK (see text for further details).

    Article Snippet: The effect of the p38 MAPK activator anisomycin on p38 MAPK phosphorylation (activation) in S. mansoni was assessed by western blotting using anti-phospho p38 MAPK (Thr180/Tyr182) monoclonal antibodies (Cell Signalling Technology, New England Biolabs, Hitchin, UK) that recognize only the phosphorylated (activated) form of the enzyme.

    Techniques: Sequencing, Binding Assay, Activation Assay, Inhibition

    Biochemical characterization of S. mansoni p38 MAPK . (A) Immunodetection of phosphorylated S. mansoni p38 MAPK. Protein from astrocytoma (U251 MG) cells (lane 1), 900 freshly-hatched swimming miracidia (lane 2), or an adult worm pair (lane 3) was processed for western blotting using anti-phospho p38 MAPK antibodies. (B) Activated S. mansoni p38 MAPK phosphorylates activating transcription factor-2 (ATF-2), and SB 203580 inhibits p38 MAPK activity. p38 MAPK from adult worm pairs was immunoprecipitated using immobilized anti-phospho p38 MAPK antibodies and the immunoprecipitated protein used in an in vitro kinase assay to phosphorylate ATF-2 either in the presence of SB 203580 (1-5 μM) or DMSO (D+), or with neither (D-). Phosphorylation of ATF-2 by immunoprecipitated p38 MAPK was assessed by western blotting using anti-phospho ATF-2 antibodies. (C) Anisomycin activates p38 MAPK in S. mansoni miracidia. Freshly-hatched miracidia were exposed to anisomycin (20 μM) for various durations and phosphorylation of p38 MAPK in miracidia detected by western blotting with anti-phospho p38 MAPK antibodies; blots were also probed with anti-actin antibodies to demonstrate equal protein loading between lanes. Results shown in (A-C) represent those obtained in at least two independent experiments.

    Journal: BMC Cell Biology

    Article Title: A role for p38 MAPK in the regulation of ciliary motion in a eukaryote

    doi: 10.1186/1471-2121-12-6

    Figure Lengend Snippet: Biochemical characterization of S. mansoni p38 MAPK . (A) Immunodetection of phosphorylated S. mansoni p38 MAPK. Protein from astrocytoma (U251 MG) cells (lane 1), 900 freshly-hatched swimming miracidia (lane 2), or an adult worm pair (lane 3) was processed for western blotting using anti-phospho p38 MAPK antibodies. (B) Activated S. mansoni p38 MAPK phosphorylates activating transcription factor-2 (ATF-2), and SB 203580 inhibits p38 MAPK activity. p38 MAPK from adult worm pairs was immunoprecipitated using immobilized anti-phospho p38 MAPK antibodies and the immunoprecipitated protein used in an in vitro kinase assay to phosphorylate ATF-2 either in the presence of SB 203580 (1-5 μM) or DMSO (D+), or with neither (D-). Phosphorylation of ATF-2 by immunoprecipitated p38 MAPK was assessed by western blotting using anti-phospho ATF-2 antibodies. (C) Anisomycin activates p38 MAPK in S. mansoni miracidia. Freshly-hatched miracidia were exposed to anisomycin (20 μM) for various durations and phosphorylation of p38 MAPK in miracidia detected by western blotting with anti-phospho p38 MAPK antibodies; blots were also probed with anti-actin antibodies to demonstrate equal protein loading between lanes. Results shown in (A-C) represent those obtained in at least two independent experiments.

    Article Snippet: The effect of the p38 MAPK activator anisomycin on p38 MAPK phosphorylation (activation) in S. mansoni was assessed by western blotting using anti-phospho p38 MAPK (Thr180/Tyr182) monoclonal antibodies (Cell Signalling Technology, New England Biolabs, Hitchin, UK) that recognize only the phosphorylated (activated) form of the enzyme.

    Techniques: Immunodetection, Western Blot, Activity Assay, Immunoprecipitation, In Vitro, Kinase Assay

    Activated p38 MAPK localizes to cilia in S. mansoni miracidia . (A) Scanning electron micrograph of the anterior of a freshly-hatched miracidium showing numerous cilia (c), and sensory endings (se) associated with the semi-spherical terebratorium (tb). (B - J) Immunolocalization of activated p38 MAPK (green) in S. mansoni miracidia following fixing and staining of parasites with anti-phospho p38 MAPK primary antibodies. (B) Freshly-hatched miracidium incubated without primary antibodies but with secondary antibodies alone (negative control). (C) Freshly-hatched swimming miracidium displaying weak patchy staining only localized adjacent to the tegument (tg) in areas corresponding to the cilia. (D) Serial optical z-section of a miracidium treated with 20 μM anisomycin for 30 min showing p38 MAPK activity in the regions occupied by cilia. (E and F) High power, optically zoomed, z-sections through discrete regions of cilia/tegument to capture the miracidium surface in one plane with (E) showing p38 MAPK localized to the shafts of the cilia (arrowed) and regions proximal to the tegument, and (F) showing co-localization with cilia (red) detected using anti-acetylated tubulin antibodies. (G) Miracidium treated with 20 μM anisomycin for 30 min for direct comparison with (C). (H) Autofluorescence (red) of S. mansoni egg containing (I, and J overlay) miracidium (m) with p38 MAPK activity in regions occupied by cilia. (K) Scanning electron micrograph of S. mansoni egg revealing common position of rupture during hatching, and correlating to rupture in H-J. Z-axis projections are shown in maximum pixel brightness mode. Bars: A, E and F = 2 μm; B-D, and G = 15 μm; H-K = 25 μm.

    Journal: BMC Cell Biology

    Article Title: A role for p38 MAPK in the regulation of ciliary motion in a eukaryote

    doi: 10.1186/1471-2121-12-6

    Figure Lengend Snippet: Activated p38 MAPK localizes to cilia in S. mansoni miracidia . (A) Scanning electron micrograph of the anterior of a freshly-hatched miracidium showing numerous cilia (c), and sensory endings (se) associated with the semi-spherical terebratorium (tb). (B - J) Immunolocalization of activated p38 MAPK (green) in S. mansoni miracidia following fixing and staining of parasites with anti-phospho p38 MAPK primary antibodies. (B) Freshly-hatched miracidium incubated without primary antibodies but with secondary antibodies alone (negative control). (C) Freshly-hatched swimming miracidium displaying weak patchy staining only localized adjacent to the tegument (tg) in areas corresponding to the cilia. (D) Serial optical z-section of a miracidium treated with 20 μM anisomycin for 30 min showing p38 MAPK activity in the regions occupied by cilia. (E and F) High power, optically zoomed, z-sections through discrete regions of cilia/tegument to capture the miracidium surface in one plane with (E) showing p38 MAPK localized to the shafts of the cilia (arrowed) and regions proximal to the tegument, and (F) showing co-localization with cilia (red) detected using anti-acetylated tubulin antibodies. (G) Miracidium treated with 20 μM anisomycin for 30 min for direct comparison with (C). (H) Autofluorescence (red) of S. mansoni egg containing (I, and J overlay) miracidium (m) with p38 MAPK activity in regions occupied by cilia. (K) Scanning electron micrograph of S. mansoni egg revealing common position of rupture during hatching, and correlating to rupture in H-J. Z-axis projections are shown in maximum pixel brightness mode. Bars: A, E and F = 2 μm; B-D, and G = 15 μm; H-K = 25 μm.

    Article Snippet: The effect of the p38 MAPK activator anisomycin on p38 MAPK phosphorylation (activation) in S. mansoni was assessed by western blotting using anti-phospho p38 MAPK (Thr180/Tyr182) monoclonal antibodies (Cell Signalling Technology, New England Biolabs, Hitchin, UK) that recognize only the phosphorylated (activated) form of the enzyme.

    Techniques: Staining, Incubation, Negative Control, Activity Assay

    p38 MAPK activation and inhibition affects S. mansoni miracidia swim velocity . Freshly-hatched swimming miracidia were collected and incubated with (A) SB 203580 (1 μM) or (B) anisomycin (20 μM) in spring water, or spring water alone, and the effects on miracidia swim behaviour over 60 min captured by digital video microscopy. Calculation of swim velocities (mm/s) for 30 miracidia for each treatment and each time point was achieved using ImageJ and mean swim speeds (± SEM) were calculated. * P ≤ 0.05, ** P ≤ 0.01, and *** P ≤ 0.001.

    Journal: BMC Cell Biology

    Article Title: A role for p38 MAPK in the regulation of ciliary motion in a eukaryote

    doi: 10.1186/1471-2121-12-6

    Figure Lengend Snippet: p38 MAPK activation and inhibition affects S. mansoni miracidia swim velocity . Freshly-hatched swimming miracidia were collected and incubated with (A) SB 203580 (1 μM) or (B) anisomycin (20 μM) in spring water, or spring water alone, and the effects on miracidia swim behaviour over 60 min captured by digital video microscopy. Calculation of swim velocities (mm/s) for 30 miracidia for each treatment and each time point was achieved using ImageJ and mean swim speeds (± SEM) were calculated. * P ≤ 0.05, ** P ≤ 0.01, and *** P ≤ 0.001.

    Article Snippet: The effect of the p38 MAPK activator anisomycin on p38 MAPK phosphorylation (activation) in S. mansoni was assessed by western blotting using anti-phospho p38 MAPK (Thr180/Tyr182) monoclonal antibodies (Cell Signalling Technology, New England Biolabs, Hitchin, UK) that recognize only the phosphorylated (activated) form of the enzyme.

    Techniques: Activation Assay, Inhibition, Incubation, Microscopy

    p38 MAPK activation accelerates the liberation of ciliated plates in transforming S. mansoni larvae . Cultures of larvae were exposed to (A) SB 203580 or (B) anisomycin, during transformation in vitro and the proportion of fully-ciliated parasites determined by microscopic examination over 50 h, compared to CBSS controls. Values shown are means (± SEM, n = 90 for each time point and each treatment from three independent experiments). *P ≤ 0.05, ** P ≤ 0.01, and *** P ≤ 0.001.

    Journal: BMC Cell Biology

    Article Title: A role for p38 MAPK in the regulation of ciliary motion in a eukaryote

    doi: 10.1186/1471-2121-12-6

    Figure Lengend Snippet: p38 MAPK activation accelerates the liberation of ciliated plates in transforming S. mansoni larvae . Cultures of larvae were exposed to (A) SB 203580 or (B) anisomycin, during transformation in vitro and the proportion of fully-ciliated parasites determined by microscopic examination over 50 h, compared to CBSS controls. Values shown are means (± SEM, n = 90 for each time point and each treatment from three independent experiments). *P ≤ 0.05, ** P ≤ 0.01, and *** P ≤ 0.001.

    Article Snippet: The effect of the p38 MAPK activator anisomycin on p38 MAPK phosphorylation (activation) in S. mansoni was assessed by western blotting using anti-phospho p38 MAPK (Thr180/Tyr182) monoclonal antibodies (Cell Signalling Technology, New England Biolabs, Hitchin, UK) that recognize only the phosphorylated (activated) form of the enzyme.

    Techniques: Activation Assay, Transformation Assay, In Vitro

    The effects of the reagents on CCD-induced mechanical allodynia. (a–d) The PWMTs of CCD rats (4 days after operation) 1, 2, 4, and 8 h after RR, 4 α -PDD, SB203580, and anisomycin intrathecal injections ( n = 6; the data are expressed as means ± SEMs); ∗ P < 0.05 and ∗∗ P < 0.01 compared ipsilaterally with the saline group; one-way ANOVA followed by Tukey's post hoc test.

    Journal: BioMed Research International

    Article Title: Effect of TRPV4-p38 MAPK Pathway on Neuropathic Pain in Rats with Chronic Compression of the Dorsal Root Ganglion

    doi: 10.1155/2016/6978923

    Figure Lengend Snippet: The effects of the reagents on CCD-induced mechanical allodynia. (a–d) The PWMTs of CCD rats (4 days after operation) 1, 2, 4, and 8 h after RR, 4 α -PDD, SB203580, and anisomycin intrathecal injections ( n = 6; the data are expressed as means ± SEMs); ∗ P < 0.05 and ∗∗ P < 0.01 compared ipsilaterally with the saline group; one-way ANOVA followed by Tukey's post hoc test.

    Article Snippet: Four days after CCD surgery, the TRPV4 inhibitor Ruthenium Red (RR, Sigma, Germany), the TRPV4 agonist 4 α -PDD (CST, USA), the p38 inhibitor SB203580 (CST, USA), or the p38 agonist anisomycin (CST, USA) was given to the experimental groups at the recommended concentrations via intrathecal injection.

    Techniques:

    Distribution changes of the p38-positive neurons in DRG tissue. (a–f) p38 immunohistochemical staining of the DRG neurons in the control, CCD, CCD+RR 10 nmol/L, CCD+4 α -PDD 10 nmol/L, CCD+SB203580 20 μ mol/L, and CCD+anisomycin 25 μ g/mL groups. Scale bars: 100 μ m. (g) The analysis of the p38-positive neurons (shown as means ± SEMs); ∗ P < 0.05 and ∗∗ P < 0.01 compared with controls; ## P < 0.01 compared with the CCD group.

    Journal: BioMed Research International

    Article Title: Effect of TRPV4-p38 MAPK Pathway on Neuropathic Pain in Rats with Chronic Compression of the Dorsal Root Ganglion

    doi: 10.1155/2016/6978923

    Figure Lengend Snippet: Distribution changes of the p38-positive neurons in DRG tissue. (a–f) p38 immunohistochemical staining of the DRG neurons in the control, CCD, CCD+RR 10 nmol/L, CCD+4 α -PDD 10 nmol/L, CCD+SB203580 20 μ mol/L, and CCD+anisomycin 25 μ g/mL groups. Scale bars: 100 μ m. (g) The analysis of the p38-positive neurons (shown as means ± SEMs); ∗ P < 0.05 and ∗∗ P < 0.01 compared with controls; ## P < 0.01 compared with the CCD group.

    Article Snippet: Four days after CCD surgery, the TRPV4 inhibitor Ruthenium Red (RR, Sigma, Germany), the TRPV4 agonist 4 α -PDD (CST, USA), the p38 inhibitor SB203580 (CST, USA), or the p38 agonist anisomycin (CST, USA) was given to the experimental groups at the recommended concentrations via intrathecal injection.

    Techniques: Immunohistochemical staining, Staining

    The effect of reagents on the protein expression of TRPV4, p38, and P-p38. (a–d) The expression of TRPV4, p38, and P-p38 proteins after RR, 4 α -PDD, SB203580, and anisomycin intrathecal injections given to rats 4 days after CCD surgery. The bars represent means ± SEMs based on six experiments; ∗ P < 0.05 and ∗∗ P < 0.01, TRPV4 compared with controls. # P < 0.05 and ## P < 0.01, p38 compared with controls. & P < 0.05 and && P < 0.01, P-p38 compared with controls.

    Journal: BioMed Research International

    Article Title: Effect of TRPV4-p38 MAPK Pathway on Neuropathic Pain in Rats with Chronic Compression of the Dorsal Root Ganglion

    doi: 10.1155/2016/6978923

    Figure Lengend Snippet: The effect of reagents on the protein expression of TRPV4, p38, and P-p38. (a–d) The expression of TRPV4, p38, and P-p38 proteins after RR, 4 α -PDD, SB203580, and anisomycin intrathecal injections given to rats 4 days after CCD surgery. The bars represent means ± SEMs based on six experiments; ∗ P < 0.05 and ∗∗ P < 0.01, TRPV4 compared with controls. # P < 0.05 and ## P < 0.01, p38 compared with controls. & P < 0.05 and && P < 0.01, P-p38 compared with controls.

    Article Snippet: Four days after CCD surgery, the TRPV4 inhibitor Ruthenium Red (RR, Sigma, Germany), the TRPV4 agonist 4 α -PDD (CST, USA), the p38 inhibitor SB203580 (CST, USA), or the p38 agonist anisomycin (CST, USA) was given to the experimental groups at the recommended concentrations via intrathecal injection.

    Techniques: Expressing

    Altered distribution of TRPV4-positive neurons in DRG tissue. (a–f) TRPV4 immunohistochemical staining of the DRG neurons in the control, CCD, CCD+RR 10 nmol/L, CCD+4 α -PDD 10 nmol/L, CCD+SB203580 20 μ mol/L, and CCD+anisomycin 25 μ g/mL groups, respectively. Scale bars: 100 μ m. (g) The analysis of the TRPV4-positive neurons (shown as means ± SEMs); ∗∗ P < 0.01 compared with controls; ## P < 0.01 compared with the CCD group.

    Journal: BioMed Research International

    Article Title: Effect of TRPV4-p38 MAPK Pathway on Neuropathic Pain in Rats with Chronic Compression of the Dorsal Root Ganglion

    doi: 10.1155/2016/6978923

    Figure Lengend Snippet: Altered distribution of TRPV4-positive neurons in DRG tissue. (a–f) TRPV4 immunohistochemical staining of the DRG neurons in the control, CCD, CCD+RR 10 nmol/L, CCD+4 α -PDD 10 nmol/L, CCD+SB203580 20 μ mol/L, and CCD+anisomycin 25 μ g/mL groups, respectively. Scale bars: 100 μ m. (g) The analysis of the TRPV4-positive neurons (shown as means ± SEMs); ∗∗ P < 0.01 compared with controls; ## P < 0.01 compared with the CCD group.

    Article Snippet: Four days after CCD surgery, the TRPV4 inhibitor Ruthenium Red (RR, Sigma, Germany), the TRPV4 agonist 4 α -PDD (CST, USA), the p38 inhibitor SB203580 (CST, USA), or the p38 agonist anisomycin (CST, USA) was given to the experimental groups at the recommended concentrations via intrathecal injection.

    Techniques: Immunohistochemical staining, Staining

    Ectopic discharges after CCD surgery and reagent injection. (a–f) represent discharges of the control, CCD, CCD+RR 10 nmol/L, CCD+4 α -PDD 10 nmol/L, CCD+SB203580 20 μ mol/L, and CCD+anisomycin 25 μ g/mL groups. Cut from BL-420E+ biological and functional experimental system. (g) and (h) show the amplitudes and frequencies for the different groups (data are expressed as means ± SEM); ∗∗ P < 0.01, compared with the CCD group (7-8 rats in each group).

    Journal: BioMed Research International

    Article Title: Effect of TRPV4-p38 MAPK Pathway on Neuropathic Pain in Rats with Chronic Compression of the Dorsal Root Ganglion

    doi: 10.1155/2016/6978923

    Figure Lengend Snippet: Ectopic discharges after CCD surgery and reagent injection. (a–f) represent discharges of the control, CCD, CCD+RR 10 nmol/L, CCD+4 α -PDD 10 nmol/L, CCD+SB203580 20 μ mol/L, and CCD+anisomycin 25 μ g/mL groups. Cut from BL-420E+ biological and functional experimental system. (g) and (h) show the amplitudes and frequencies for the different groups (data are expressed as means ± SEM); ∗∗ P < 0.01, compared with the CCD group (7-8 rats in each group).

    Article Snippet: Four days after CCD surgery, the TRPV4 inhibitor Ruthenium Red (RR, Sigma, Germany), the TRPV4 agonist 4 α -PDD (CST, USA), the p38 inhibitor SB203580 (CST, USA), or the p38 agonist anisomycin (CST, USA) was given to the experimental groups at the recommended concentrations via intrathecal injection.

    Techniques: Injection, Functional Assay

    Effect of HMSeBA supplementation on the expression of selenoproteins and the antioxidative capacity in IPEC-J2 cells. IPEC-J2 cells were treated with 1.2 μM HMSeBA for 24 h. (A) Relative mRNA levels of selenoproteins. n = 3 for each group. (B) Relative protein abundance of GPX4, SELENOS and SELENOP. n = 4 for each group. (C) The activity of antioxidant related enzymes. n = 6 for each group. GSH-Px, glutathione peroxidase; T-SOD, total superoxide dismutase; CAT, catalase; T-AOC, total antioxidant capacity. Data are expressed as mean ± SE. * P < 0.05, ** P < 0.01, *** P < 0.001.

    Journal: Frontiers in Nutrition

    Article Title: Maternal Organic Selenium Supplementation Relieves Intestinal Endoplasmic Reticulum Stress in Piglets by Enhancing the Expression of Glutathione Peroxidase 4 and Selenoprotein S

    doi: 10.3389/fnut.2022.900421

    Figure Lengend Snippet: Effect of HMSeBA supplementation on the expression of selenoproteins and the antioxidative capacity in IPEC-J2 cells. IPEC-J2 cells were treated with 1.2 μM HMSeBA for 24 h. (A) Relative mRNA levels of selenoproteins. n = 3 for each group. (B) Relative protein abundance of GPX4, SELENOS and SELENOP. n = 4 for each group. (C) The activity of antioxidant related enzymes. n = 6 for each group. GSH-Px, glutathione peroxidase; T-SOD, total superoxide dismutase; CAT, catalase; T-AOC, total antioxidant capacity. Data are expressed as mean ± SE. * P < 0.05, ** P < 0.01, *** P < 0.001.

    Article Snippet: The PVDF membrane was then blocked with 1% BSA containing TBST, followed by incubation with primary antibodies at 4°C for more than 8 h. The primary antibodies were as follows: SELS (21 KDa, 15591-1-AP, Proteintech), GPX4 (22 KDa, 52455S, Cell Signaling Technology), SEPP1 (57/45 KDa, sc-376858, Santa Cruz Biotechnology), GRP78 (78 KDa, ab21685, Abcam), p-IRE1α (110 KDa, ab48187, Abcam), IRE1α (110 KDa, ab37073, Abcam), p-PERK (170 KDa, 3179S, Cell Signaling Technology), PERK (170 KDa, 3192S, Cell Signaling Technology), CHOP (27 KDa, 381679, Zen BioScience) and β-actin (45 kDa, #4967, Cell Signaling Technology).

    Techniques: Expressing, Activity Assay

    Roles of GPX4 and SELENOS in regulating ER stress induced by H 2 O 2 in IPEC-J2 cells. (A) IPEC-J2 cells were infected with AdshGPX4, then were treated with H 2 O 2 plus HMSeBA. Protein levels of ER stress related markers were detected. (B) IPEC-J2 cells were infected with AdshSELS, then were treated with H 2 O 2 plus HMSeBA. Protein levels of ER stress related markers were detected. (C) IPEC-J2 cells were infected with AdshGPX4 or/and AdshSELS, then were treated with H 2 O 2 . Protein levels of ER stress related markers were detected n = 4 or 3 for western blot assay. Data are expressed as mean ± SE. * P < 0.05, ** P < 0.01, *** P < 0.001.

    Journal: Frontiers in Nutrition

    Article Title: Maternal Organic Selenium Supplementation Relieves Intestinal Endoplasmic Reticulum Stress in Piglets by Enhancing the Expression of Glutathione Peroxidase 4 and Selenoprotein S

    doi: 10.3389/fnut.2022.900421

    Figure Lengend Snippet: Roles of GPX4 and SELENOS in regulating ER stress induced by H 2 O 2 in IPEC-J2 cells. (A) IPEC-J2 cells were infected with AdshGPX4, then were treated with H 2 O 2 plus HMSeBA. Protein levels of ER stress related markers were detected. (B) IPEC-J2 cells were infected with AdshSELS, then were treated with H 2 O 2 plus HMSeBA. Protein levels of ER stress related markers were detected. (C) IPEC-J2 cells were infected with AdshGPX4 or/and AdshSELS, then were treated with H 2 O 2 . Protein levels of ER stress related markers were detected n = 4 or 3 for western blot assay. Data are expressed as mean ± SE. * P < 0.05, ** P < 0.01, *** P < 0.001.

    Article Snippet: The PVDF membrane was then blocked with 1% BSA containing TBST, followed by incubation with primary antibodies at 4°C for more than 8 h. The primary antibodies were as follows: SELS (21 KDa, 15591-1-AP, Proteintech), GPX4 (22 KDa, 52455S, Cell Signaling Technology), SEPP1 (57/45 KDa, sc-376858, Santa Cruz Biotechnology), GRP78 (78 KDa, ab21685, Abcam), p-IRE1α (110 KDa, ab48187, Abcam), IRE1α (110 KDa, ab37073, Abcam), p-PERK (170 KDa, 3179S, Cell Signaling Technology), PERK (170 KDa, 3192S, Cell Signaling Technology), CHOP (27 KDa, 381679, Zen BioScience) and β-actin (45 kDa, #4967, Cell Signaling Technology).

    Techniques: Infection, Western Blot

    General view of the effect of HMSeBA on intestinal ER stress. A model for HMSeBA supplementation regulates ER stress induced by LPS or H 2 O 2 in vivo and vitro . Only core components of the pathway are shown. LPS or H 2 O 2 administration induce ER stress through activating the GRP78-IRE1α-CHOP signaling pathway. While HMSeBA treatment improves the expression of GPX4 and SELS, thereby suppresses the ER stress signal, ameliorates the redox status. Maternal HMSeBA is involved in regulating the ER stress signal and health of intestine.

    Journal: Frontiers in Nutrition

    Article Title: Maternal Organic Selenium Supplementation Relieves Intestinal Endoplasmic Reticulum Stress in Piglets by Enhancing the Expression of Glutathione Peroxidase 4 and Selenoprotein S

    doi: 10.3389/fnut.2022.900421

    Figure Lengend Snippet: General view of the effect of HMSeBA on intestinal ER stress. A model for HMSeBA supplementation regulates ER stress induced by LPS or H 2 O 2 in vivo and vitro . Only core components of the pathway are shown. LPS or H 2 O 2 administration induce ER stress through activating the GRP78-IRE1α-CHOP signaling pathway. While HMSeBA treatment improves the expression of GPX4 and SELS, thereby suppresses the ER stress signal, ameliorates the redox status. Maternal HMSeBA is involved in regulating the ER stress signal and health of intestine.

    Article Snippet: The PVDF membrane was then blocked with 1% BSA containing TBST, followed by incubation with primary antibodies at 4°C for more than 8 h. The primary antibodies were as follows: SELS (21 KDa, 15591-1-AP, Proteintech), GPX4 (22 KDa, 52455S, Cell Signaling Technology), SEPP1 (57/45 KDa, sc-376858, Santa Cruz Biotechnology), GRP78 (78 KDa, ab21685, Abcam), p-IRE1α (110 KDa, ab48187, Abcam), IRE1α (110 KDa, ab37073, Abcam), p-PERK (170 KDa, 3179S, Cell Signaling Technology), PERK (170 KDa, 3192S, Cell Signaling Technology), CHOP (27 KDa, 381679, Zen BioScience) and β-actin (45 kDa, #4967, Cell Signaling Technology).

    Techniques: In Vivo, Expressing